UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1/A
Amendment No. 1
Registration Statement Under
THE SECURITIES ACT OF 1933
| ELEMENTS VENTURES GROUP INC. |
| (Exact name of registrant as specified in charter) |
| Wyoming |
| 7370 |
| N/A |
| (State or other jurisdiction |
| (Primary Standard Classi- |
| (IRS Employer |
| of incorporation) |
| fication Code Number) |
| I.D. Number) |
Elements Ventures Group Inc.
9980 Dufferin Street #20026
Vaughan, Ontario L6A 4M4
(647) 405-1054
elementsvg@protonmail.com
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)
Dmitry Kinslikh, Chief Executive Officer
Elements Ventures Group Inc.
9980 Dufferin Street #20026
Vaughan, Ontario L6A 4M4
(647) 405-1054
elementsvg@protonmail.com
Address, including zip code, and telephone number,
including area code, of agent for service)
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☒ |
| (Do not check if a smaller reporting company) |
| Emerging growth company | ☒ |
If an emerging growth company, indicate by checkmark if the registrant has not elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☒
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon as practicable after the effective date of this Registration Statement
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF THE SECURITIES ACT OF 1933, OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SECTION 8(A), MAY DETERMINE.
The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
PROSPECTUS (Subject to Completion)
Dated October ___, 2026
PRELIMINARY PROSPECTUS
ELEMENTS VENTURES GROUP INC.
6,000,000 SHARES OF COMMON STOCK
NO MINIMUM
AND
4,817,167 SHARES OF COMMON STOCK OFFERED BY THE SELLING STOCKHOLDERS
$0.35 PER SHARE
This is the initial public offering of the shares of common stock of Elements Ventures Group Inc., a Wyoming company (“we”, “us”, “our”, “Elements”, the “Company” or similar terms). We are offering for sale a total of 6,000,000 shares of our Common Stock at a price of $0.35 per share in a "self-underwritten", best effort, no minimum basis. Subscription funds that are accepted by us will be deposited directly into its operating account and will not be held in escrow. The funds will be available for our immediate use. In addition, the selling stockholders are selling 4,817,167 shares of common stock at a price of $0.35 per share. We will not receive proceeds from the sale of any shares by the selling stockholders. The selling stockholders named herein may be deemed underwriters within the meaning of the Securities Act of 1933, as amended. This offering will terminate 365 days from the date of this prospectus, unless extended by our Board of Directors for an additional 90 days or terminated. We have arbitrarily determined the offering price of $0.35 per share in relation to this offering. The offering price bears no relationship to our assets, book value, earnings or any other customary investment criteria. We are making this offering without the involvement of underwriters or broker-dealers.
Prior to this offering, there has been no public market for our common stock. After the effective date of the registration statement, we intend to seek a market maker to file an application with the Financial Industry Regulatory Authority (“FINRA”) for a trading symbol and to have our common stock quoted on the OTC Pink Market. There is no assurance that an active trading market for our shares will develop or will be sustained if developed.
We qualify as an “emerging growth company” as defined in the Jumpstart our Business Startups Act (the “JOBS Act”).
Our sole officer and director Dmitry Kinslikh owns 59.2% of our currently outstanding common stock. If we are to sell all of the shares we are registering in this offering, Mr. Kinslikh will own 39.8% of our outstanding common stock. Mr. Kinslikh’s father, Izrael Kinslikh is selling up to 500,000 shares in this offering. Other than his father, no other member of his immediate family are selling any shares in this offering.
Purchase of our common stock involves a high degree of risk. You should carefully consider the factors described under the heading “Risk Factors” before investing in our shares of common stock.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
THE DATE OF THIS PROSPECTUS IS October ____, 2026
| 2 |
| Table of Contents |
|
| 5 |
| |
|
| 8 |
| |
|
| 8 |
| |
|
| 12 |
| |
|
| 15 |
| |
|
| 16 |
| |
|
| 16 |
| |
|
| 17 |
| |
|
| 20 |
| |
|
| 18 |
| |
|
| 21 |
| |
|
| 33 |
| |
|
| 33 |
| |
| Management’s Discussion and Analysis of Financial Condition and Results of Operations |
| 36 |
|
| Directors, Executive Officers, Promoters and Control Persons |
| 41 |
|
|
| 42 |
| |
| Security Ownership of Certain Beneficial Owners and Management |
| 42 |
|
|
| 43 |
| |
| Disclosure of Commission Position on Indemnification for Securities Act Liabilities |
|
|
|
|
| 43 |
| |
|
| 43 |
| |
| Changes In and Disagreements with Accountants on Accounting and Financial Disclosure |
| 38 |
|
|
| F-1 |
|
| 3 |
| Table of Contents |
You should rely only on information contained in this prospectus. We have not authorized any other person to provide you with different information. This prospectus is not an offer to sell, nor is it seeking an offer to buy, these securities in any state where the offer or sale is not permitted. The information in this prospectus is complete and accurate as of the date on the front cover, but the information may have changed since that date.
Until ____________, 2026 (90 business days after the effective date of this prospectus) all dealers that effect transactions in these securities whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealer’s obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. We do not expect to have any dealer transactions within the 90 business day period because we will not have a public market until after that period, if we ever have a public market.
A CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus contains forward-looking statements, which relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled “Risk Factors,” that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
We cannot provide any assurance that we will be able to raise sufficient funds from this offering to proceed with our twelve-month business plan.
While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested herein. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.
| 4 |
| Table of Contents |
Our Business
We are a development stage company and were incorporated in Wyoming on January 31, 2022. Dmitry Kinslikh is our founder. Our address is 9980 Dufferin Street #20026, Vaughan, Ontario L6A 4M4 and our telephone number is (647) 405-1054.
Since inception we have generated no revenues and have accumulated a deficit of $156,402 to May 31, 2026. To implement our plan of operations we require a minimum funding of $80,000 for the next twelve months. Our independent auditor has issued an audit opinion for our Company, which includes a statement expressing a doubt as to our ability to continue as a going concern.
We are an “emerging growth company” within the meaning of the federal securities laws. For as long as we are an emerging growth company, we will not be required to comply with the requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, the reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and the exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. We intend to take advantage of these reporting exemptions until we are no longer an emerging growth company. For a description of the qualifications and other requirements applicable to emerging growth companies and certain elections that we have made due to our status as an emerging growth company, see “RISK FACTORS RISKS RELATED TO THIS OFFERING AND OUR COMMON STOCK - WE ARE AN “EMERGING GROWTH COMPANY” AND WE CANNOT BE CERTAIN IF THE REDUCED DISCLOSURE REQUIREMENTS APPLICABLE TO EMERGING GROWTH COMPANIES WILL MAKE OUR COMMON STOCK LESS ATTRACTIVE TO INVESTORS” on page 15 of this prospectus.
We contend that we are not a “shell company” within the meaning of Rule 405 or a blank check company because we have a defined business plan which we have begun executing and we no plans or intentions to engage in a merger with or acquisition of an unidentified company, companies, entity or person.
Our business is the development and intended commercialization of FITLY, a consumer mobile application for general health and wellness. FITLY is designed to help individuals pursue general fitness, nutrition, and healthy-lifestyle goals through meal and habit tracking, wearable-device synchronization, structured multi-week wellness programs, and an assistive conversational feature that provides general wellness information.
We have not launched FITLY. The application is code-complete and has passed our internal quality-assurance review, but it has not been deployed, has not been tested by users, and has not been submitted to the Apple App Store or Google Play Store. We have no users, no customers and no revenue.
| 5 |
| Table of Contents |
The Offering
| Securities offered by the Company:
| 6,000,000 shares of our common stock, par value $0.0001 per share. |
| Securities Being Offered by the Selling Shareholders: | 4,817,167 shares of our common stock, par value $0.0001 per share. |
| Offering price:
| $0.35 |
| Duration of offering:
| The shares are being offered for a period not to exceed 365 days, unless extended by our Board of Directors for an additional 90 days. |
| Gross proceeds to us:
| $2,100,000, assuming the maximum number of shares sold. For further information on the Use of Proceeds, see page 21 |
| Market for the common stock:
| There is no public market for our shares. After the effective date of the registration statement relating to this prospectus, we intend to have a market maker file an application with the Financial Industry Regulatory Authority (“FINRA”) for our common stock to eligible for trading on the OTC Pink Market.
|
| Shares outstanding prior to offering:
| 11,817,167 |
| Shares outstanding after offering:
| 17,817,167 (assuming all the shares are sold) |
| Risk Factors: | The common stock offered hereby involves a high degree of risk and should not be purchased by investors who cannot afford the loss of their entire investment. See “Risk Factors” beginning on page 14. |
| 6 |
| Table of Contents |
EMERGING GROWTH COMPANY
We are an Emerging Growth Company as defined in the Jumpstart Our Business Startups Act.
We shall continue to be deemed an emerging growth company until the earliest of:
|
| a. | The last day of the fiscal year of the issuer during which it had total annual gross revenues of $1,000,000,000 (as such amount is indexed for inflation every 5 years by the Commission to reflect the change in the Consumer Price Index for All Urban Consumers published by the Bureau of Labor Statistics, setting the threshold to the nearest 1,000,000) or more; |
|
|
|
|
|
| b. | The last day of the fiscal year of the issuer following the fifth anniversary of the date of the first sale of common equity securities of the issuer pursuant to an effective registration statement under this title; |
|
|
|
|
|
| c. | The date on which such issuer has, during the previous 3-year period, issued more than $1,000,000,000 in non-convertible debt; or |
|
|
|
|
|
| d. | The date on which such issuer is deemed to be a “large accelerated filer”, as defined in section 240.12b-2 of title 17, Code of Federal Regulations, or any successor thereto. |
As an emerging growth company, we are exempt from Section 404(b) of Sarbanes Oxley. Section 404(a) requires Issuers to publish information in their annual reports concerning the scope and adequacy of the internal control structure and procedures for financial reporting. This statement shall also assess the effectiveness of such internal controls and procedures.
Section 404(b) requires that the registered accounting firm shall, in the same report, attest to and report on the assessment on the effectiveness of the internal control structure and procedures for financial reporting.
As an emerging growth company, we are exempt from Section 14A and B of the Securities Exchange Act of 1934 which require the shareholder approval of executive compensation and golden parachutes.
We have irrevocably opted out of the extended transition period for complying with new or revised accounting standards pursuant to Section 107(b) of the Act.
Smaller Reporting Company
Implications of being an emerging growth company - the JOBS Act
We qualify as an emerging growth company as that term is used in the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other burdens that are otherwise applicable generally to public companies. These provisions include:
|
| · | A requirement to have only two years of audited financial statements and only two years of related MD&A; |
|
|
|
|
|
| · | Exemption from the auditor attestation requirement in the assessment of the emerging growth company’s internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002; |
|
|
|
|
|
| · | Reduced disclosure about the emerging growth company’s executive compensation arrangements; and |
|
|
|
|
|
| · | No non-binding advisory votes on executive compensation or golden parachute arrangements. |
We may take advantage of the reduced reporting requirements applicable to smaller reporting companies even if we no longer qualify as an “emerging growth company”.
In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”) for complying with new or revised accounting standards. We have irrevocably opted out of the extended transition period for complying with new or revised accounting standards pursuant to Section 107(b) of the Act.
We could remain an emerging growth company for up to five years, or until the earliest of (i) the last day of the first fiscal year in which our annual gross revenues exceed $1 billion, (ii) the date that we become a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter, or (iii) the date on which we have issued more than $1 billion in non-convertible debt during the preceding three year period.
| 7 |
| Table of Contents |
An investment in our common stock involves a high degree of risk. This section includes all of the known material risks in the offering. You should carefully consider the risks described below and the other information in this prospectus before investing in our common stock. If any of the following risks occur, our business, operating results and financial condition could be seriously harmed. The trading price of our common stock, when and if we trade at a later date, could decline due to any of these risks, and you may lose all or part of your investment.
RISKS ASSOCIATED TO OUR BUSINESS
WE HAVE NOT EARNED REVENUE AS OF MAY 31, 2026 AND OUR ABILITY CONTINUE OUR OPERATIONS IS DEPENDENT ON OUR ABILITY TO RAISE FINANCING. OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANT HAS EXPRESSED SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO CONTINUE AS A GOING CONCERN.
We have accrued net losses of $156,402 for the period since our inception on January 31, 2022 to May 31, 2026, and have no revenues as of this date. Our future is dependent upon our ability to obtain financing and upon future profitable operations in the technology business. Further, the finances required to fully develop our plan cannot be predicted with any certainty and may exceed any estimates we set forth. These factors raise a doubt that we will be able to continue as a going concern. Michael Gillespie & Associates, PLLC our independent registered public accounting firm has expressed a doubt about our ability to continue as a going concern. This opinion could materially limit our ability to raise additional funds by issuing new debt or equity securities or otherwise. If we fail to raise sufficient capital when needed, our director Dmitry Kinslikh has agreed to give us an interest-free loan to fund our operations. Otherwise, we will not be able to complete our business plan. As a result, we may have to liquidate our business and you may lose your investment. You should consider our independent registered public accountant’s comments when determining whether to make an investment.
FITLY HAS NOT BEEN DEPLOYED, TESTED BY USERS, OR APPROVED BY THE APP STORES, AND MAY NEVER LAUNCH SUCCESSFULLY.
Although our codebase is complete and has passed internal quality-assurance review, the application has not been deployed to a production environment, has not been tested by real users, and has not been submitted to or approved by the Apple App Store or Google Play Store. Internal review is not a substitute for real-world testing. We may encounter technical, operational, or app-store-approval problems that delay or prevent launch. Apple and Google have broad discretion to reject or remove applications, and our application may not be approved.
WE ARE DEPENDENT UPON THE FUNDS TO BE RAISED IN THIS OFFERING TO CONTINUE OUR BUSINESS, THE PROCEEDS OF WHICH MAY BE INSUFFICIENT TO ACHIEVE REVENUES AND PROFITABLE OPERATIONS. WE MAY NEED TO OBTAIN ADDITIONAL FINANCING.
Our current operating funds are less than necessary to complete our intended operations in the technology business. We need the proceeds from this offering to start our operations as described in the “Plan of Operation” section of this prospectus. As of May 31, 2026, we had cash in the amount of $13,968 and liabilities of $109,776. The proceeds of this offering may not be sufficient for us to achieve additional revenues and profitable operations. We may need additional funds to achieve a sustainable sales level where ongoing operations can be funded out of revenues. Please see the section titled “Plan of Operations” for a description of possible funding from our director.
We require a minimum funding of approximately $80,000 to conduct our proposed operations for a period of one year. After one year we may need additional financing. If we do not generate any revenue, we may need a minimum of $20,000 in additional funding to pay for ongoing SEC filing requirements. Even if we generate revenues, such revenues may be insufficient to cover our ongoing SEC filing requirements so we may need to seek additional financing to cover those costs. We do not currently have any arrangements for additional financing.
| 8 |
| Table of Contents |
If we are successful in raising the funds from this offering, we plan to commence activities to continue our operations. We cannot provide investors with any assurance that we will be able to raise sufficient funds to continue our business plan according to our plan of operations.
WE REQUIRE ADDITIONAL CAPITAL AND FINANCING TO CONTINUE OUR BUSINESS AND FAILURE TO OBTAIN CAPITAL COULD CAUSE OUR BUSINESS TO FAIL.
The accompanying financial statements have been prepared assuming that we will continue as a going concern. As discussed in the Notes of our May 31, 2026 financial statements, we are in the development stage of operations, have had losses from operations since inception, no revenues and insufficient working capital available to implement our business plan and to meet ongoing financial obligations over the next fiscal year. Our Auditor has raised “substantial doubt regarding the Company's ability to continue as a going concern”, or in other words remain in business. We will require additional capital and financing in order to continue otherwise our business will fail. We have made no definitive arrangements for any additional capital or financing.
WE ARE A DEVELOPMENT STAGE COMPANY AND HAVE COMMENCED LIMITED OPERATIONS IN OUR BUSINESS. WE EXPECT TO INCUR SIGNIFICANT OPERATING LOSSES FOR THE FORESEEABLE FUTURE.
We were incorporated on January 31, 2022 and have commenced limited business operations. Accordingly, we have no way to evaluate the likelihood that our business will be successful. Potential investors should be aware of the difficulties normally encountered by new companies and the high rate of failure of such enterprises. The likelihood of success must be considered in light of the problems, expenses, difficulties, complications and delays encountered in connection with the operations that we plan to undertake. These potential problems include, but are not limited to, unanticipated problems relating to the ability to generate sufficient cash flow to operate our business, and additional costs and expenses that may exceed current estimates. We anticipate that we will incur increased operating expenses without realizing significant revenues. We expect to incur significant losses in the foreseeable future. We recognize that if the effectiveness of our business plan is not forthcoming, we will not be able to continue business operations. There is no history upon which to base any assumption as to the likelihood that we will prove successful. If we are unsuccessful in addressing these risks, our business will most likely fail.
BECAUSE WE ARE SMALL AND DO NOT HAVE MUCH CAPITAL, OUR MARKETING CAMPAIGN MAY NOT BE ENOUGH TO ATTRACT SUFFICIENT NUMBER OF CUSTOMERS TO OPERATE PROFITABLY. IF WE DO NOT MAKE A PROFIT, WE WILL SUSPEND OR CEASE OPERATIONS.
Although we are yet to begin selling our products, due to the fact we are small and do not have much capital, we must limit our marketing activities and may not be able to make our products/services known to potential customers. Because we will be limiting our marketing activities, we may not be able to attract enough customers to operate profitably. If we cannot operate profitably, we may have to suspend or cease operations.
BECAUSE OUR SOLE OFFICER AND DIRECTOR OWNS MORE THAN 50% OF OUR OUTSTANDING COMMON STOCK, IF ONLY 25% OF THE SHARES BEING OFFERED ARE SOLD, HE WILL MAKE AND CONTROL CORPORATE DECISIONS THAT MAY BE DISADVANTAGEOUS TO MINORITY SHAREHOLDERS.
If only 25% of our offering shares are sold, Mr. Dmitry Kinslikh, our sole officer and director, will own more than 50% of the outstanding shares of our common stock. Accordingly, he will have significant influence in determining the outcome of all corporate transactions or other matters, including the election of directors, mergers, consolidations and the sale of all or substantially all of our assets, and also the power to prevent or cause a change in control. The interests of Mr. Dmitry Kinslikh may differ from the interests of the other stockholders and may result in corporate decisions that are disadvantageous to other shareholders.
| 9 |
| Table of Contents |
MR. DMITRY KINSLIKH, OUR SOLE DIRECTOR, WILL BE ABLE TO DETERMINE HIS OWN SALARY AND PERQUISITES, WHICH COULD ADVERSELY AFFECT OUR INCOME.
Because our sole executive officer occupies all corporate positions, it may not be possible to have adequate internal controls. As the sole director, Mr. Dmitry Kinslikh has the sole authority to appoint our officers and determine their compensation. Accordingly, Mr. Dmitry Kinslikh could determine, as our sole director that his salary and perquisites are equal to or exceed our net income, if we ever have an income. In the event that Mr. Dmitry Kinslikh does determine that he is entitled to a salary and/or perquisites, investors will have no mechanism by which to revise his salary and perquisites since he controls a majority of the voting securities of the Company and will continue to do so even after the offering.
OUR INTERNAL CONTROLS MAY BE INADEQUATE, WHICH COULD CAUSE OUR FINANCIAL REPORTING TO BE UNRELIABLE AND LEAD TO MISINFORMATION BEING DISSEMINATED TO THE PUBLIC. AS A RESULT, OUR STOCKHOLDERS COULD LOSE CONFIDENCE IN OUR FINANCIAL RESULTS, WHICH COULD HARM OUR BUSINESS AND THE MARKET VALUE OF OUR COMMON SHARES.
Effective internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. We may in the future discover areas of our internal controls that need improvement. Section 404 of the Sarbanes-Oxley Act of 2002 will require us to continue to evaluate and to report on our internal controls over financial reporting. We cannot be certain that we will be successful in continuing to maintain adequate control over our financial reporting and financial processes. Furthermore, if our business grows, our internal controls will become more complex, and we will require significantly more resources to ensure our internal controls remain effective. Additionally, the existence of any material weakness or significant deficiency would require management to devote significant time and incur significant expense to remediate any such material weaknesses or significant deficiencies and management may not be able to remediate any such material weaknesses or significant deficiencies in a timely manner.
KEY MANAGEMENT PERSONNEL MAY LEAVE THE COMPANY, WHICH COULD ADVERSELY AFFECT THE ABILITY OF THE COMPANY TO CONTINUE OPERATIONS.
The Company is entirely dependent on the efforts of its sole officer and director Dmitry Kinslikh. The Company does not have an employment agreement in place with its sole officer and director. His departure or the loss of any other key personnel in the future could have a material adverse effect on the business. There is no guarantee that replacement personnel, if any, will help the Company to operate profitably. The Company does not maintain key person life insurance on its sole officer and director.
WE DO NOT MAINTAIN ANY INSURANCE AND DO NOT INTEND TO MAINTAIN INSURANCE IN THE FUTURE.
We do not maintain any insurance and do not intend to maintain insurance in the foreseeable future. Because we do not have any insurance, if we are made a part of a products liability action, we may not have sufficient funds to defend the litigation. If that occurs a judgment could be rendered against us that could cause us to cease operations.
OUR SOLE OFFICER AND DIRECTOR HAS NO EXPERIENCE MANAGING A PUBLIC COMPANY THAT IS REQUIRED TO ESTABLISH AND MAINTAIN DISCLOSURE CONTROL AND PROCEDURES AND INTERNAL CONTROL OVER FINANCIAL REPORTING.
We have never operated as a public company. Dmitry Kinslikh, our sole officer and director has no experience managing a public company that is required to establish and maintain disclosure controls and procedures and internal control over financial reporting. As a result, we may not be able to operate successfully as a public company, even if our operations are successful. We plan to comply with all of the various rules and regulations, which are required for a public company that is reporting company with the Securities and Exchange Commission. However, if we cannot operate successfully as a public company, your investment may be materially adversely affected.
| 10 |
| Table of Contents |
OUR PRESIDENT, MR. DMITRY KINSLIKH DOES NOT HAVE ANY PRIOR EXPERIENCE IN SELLING STOCK, AND OUR BEST EFFORT OFFERING DOES NOT REQUIRE A MINIMUM AMOUNT TO BE RAISED. AS A RESULT OF THIS WE MAY NOT BE ABLE TO RAISE ENOUGH FUNDS TO START OUR BUSINESS AND INVESTORS MAY LOSE THEIR ENTIRE INVESTMENT.
Mr. Dmitry Kinslikh does not have any experience in selling stocks. Consequently, we may not be able to raise any funds successfully. Also, the best effort offering does not require a minimum amount to be raised. If we are not able to raise sufficient funds, we may not be able to fund our operations as planned, and our business will suffer and your investment may be materially adversely affected. Our inability to successfully conduct a best-effort offering could be the basis of your losing your entire investment in us.
WE DEPEND ON A SINGLE THIRD-PARTY AI PROVIDER FOR KEY FEATURES OF FITLY
FITLY’s conversational coaching and photo meal analysis features depend on services provided by a single third-party AI provider under its standard commercial terms. We do not have a separately negotiated agreement with this provider and have not yet tested these features against live production systems. Any interruption, limitation, pricing change or termination of these services could delay or impair the operation and development of FITLY and could materially adversely affect our business.
IT MAY BE DIFFICULT FOR INVESTORS TO EFFECT SERVICE OF PROCESS ON OR ENFORCE U.S. JUDGMENTS AGAINST OUR SOLE OFFICER.
Our sole officer resides in Canada. As a result, it may be more difficult or costly for U.S. investors to effect service of process upon our officer or to enforce judgments obtained in U.S. courts against him. This may limit the ability of investors to pursue claims or remedies against our officer under U.S. securities laws.
WE OPERATE IN A HIGHLY COMPETITIVE MARKET AND MAY BE UNABLE TO COMPETE SUCCESSFULLY.
The market for digital health, nutrition, fitness and AI-enabled wellness applications is highly competitive and continues to evolve rapidly. We compete, or may compete, with established health and fitness applications, nutrition and calorie-tracking platforms, AI-enabled coaching services and new market entrants, many of which may have greater financial, technical, marketing and other resources than we do. Our competitors may offer products with similar or more advanced features, stronger brand recognition, larger user bases or lower pricing. Because barriers to entry in our market may be relatively low, additional competitors could enter the market and replicate or improve upon features offered by FITLY.
Our ability to compete successfully will depend on our ability to differentiate FITLY, attract and retain users, continue developing useful features and respond to changes in technology and consumer preferences. If we are unable to compete effectively, our ability to attract users, generate revenue and achieve profitability could be materially adversely affected.
OUR COLLECTION AND PROCESSING OF HEALTH, BIOMETRIC, NUTRITION AND WEARABLE DATA SUBJECTS US TO PRIVACY AND DATA PROTECTION RISKS AND REGULATORY REQUIREMENTS.
We collect and process information that may be considered sensitive personal information, including health, biometric, nutrition and wearable-device data. Our employer and health-plan dashboard may also involve the processing or disclosure of such information. Depending on how our products and services are offered and used, we may be subject to U.S. federal and state privacy, consumer health and data protection laws and Canadian federal and provincial privacy laws. Certain state laws specifically regulate consumer health information outside the scope of HIPAA and may impose requirements relating to consent, disclosure, deletion and other consumer rights.
These laws and regulations are evolving and may impose requirements relating to notice and consent, data collection and use, security safeguards, data sharing, retention, deletion and breach notification. We may also be required to implement additional safeguards or restrictions regarding information made available to employers or health plans. Any failure by us or our service providers to comply with applicable privacy and data protection requirements, or any unauthorized access to or disclosure of sensitive information, could result in regulatory investigations, penalties, litigation, increased compliance costs, reputational harm and loss of users or customers, any of which could materially adversely affect our business and results of operations.
| 11 |
| Table of Contents |
RISK FACTORS RELATING TO OUR COMMON STOCK
ANY ADDITIONAL FUNDING WE ARRANGE THROUGH THE SALE OF OUR COMMON STOCK WILL RESULT IN DILUTION TO EXISTING SHAREHOLDERS.
We must raise additional capital in order for our business plan to succeed. Our most likely source of additional capital will be through the sale of additional shares of common stock. Such stock issuances will cause stockholders’ interests in our company to be diluted. Such dilution will negatively affect the value of an investor's shares.
IF WE ARE CONSIDERED A "SHELL COMPANY," THE TRADABILITY OF OUR SHARES WILL BE LIMITED.
If we are considered a "shell company" within the meaning of Rule 12b-2 pursuant to the Securities Exchange Act of 1934 and Rule 405 pursuant to the Securities Act of 1933, the ability of holders of our common stock to sell their shares may be limited by applicable regulations. If we are deemed a shell company, as a result of such classification, our investors would not be allowed to rely on the "safe harbor" provisions of Rule 144, promulgated pursuant to the Securities Act of 1933, so as not to be considered underwriters in connection with the sale of our securities until one year from the date that we would cease to be a shell company. In such event, this would likely make it more difficult for us to attract additional capital through subsequent unregistered offerings because purchasers of securities in such unregistered offerings will not be able to resell their securities in reliance on Rule 144, a safe harbor on which holders of restricted securities usually rely to resell securities. Additionally, we would not be able to register our securities on Form S-8 (an abbreviated form of registration statement). We can provide no assurance or guarantee that we will not be considered a shell company and, accordingly, we can provide no assurance or guarantee that there will be a liquid market for our shares. Resultantly, investors would not be able to sell their shares and may lose their entire investment.
WE ARE AN EMERGING GROWTH COMPANY AND MAY TAKE ADVANTAGE OF REDUCED DISCLOSURE REQUIREMENTS APPLICABLE TO EMERGING GROWTH COMPANIES, WHICH COULD MAKE OUR SECURITIES LESS ATTRACTIVE TO INVESTORS.
We qualify as an “emerging growth company” under applicable federal securities laws. As an emerging growth company, we may take advantage of certain exemptions from disclosure and other requirements that generally apply to public companies, including reduced executive compensation disclosure and exemptions from certain auditor attestation requirements relating to internal control over financial reporting.
We may take advantage of some or all of these reduced reporting requirements for as long as we qualify as an emerging growth company. As a result, the information we provide to investors may be different from, or less extensive than, the information provided by other public companies. If investors consider our reduced disclosure less informative, our securities may be less attractive to investors, which could adversely affect the trading market and market price of our securities.
RISKS ASSOCIATED WITH PURCHASE OF OUR SHARES
OUR OFFERING IS BEING MADE ON A BEST-EFFORTS BASIS WITH NO MINIMUM AMOUNT OF SHARES ARE REQUIRED TO BE SOLD FOR THE OFFERING TO PROCEED.
In order to implement our business plan, we require funds from this offering. We require a minimum of $80,000 from the offering to implement your business plan. However, our offering is being made on a best-efforts basis with no minimum amount of shares required to be sold in the offering to proceed. If we raise only a nominal amount of the proceeds we may be unable to implement our business plan and we will have to suspend or cease operations and you may lose your investment in our company. In addition, because there is no minimum offering amount, our ability to close the offering early poses a risk of loss of your investment in our company.
| 12 |
| Table of Contents |
BECAUSE THE COMPANY HAS ARBITRARILY SET THE OFFERING PRICE, YOU MAY NOT REALIZE A RETURN ON YOUR INVESTMENT UPON RESALE OF YOUR SHARES.
The offering price and other terms and conditions relative to the Company’s shares have been arbitrarily determined by us and do not bear any relationship to assets, earnings, book value or any other objective criteria of value. Additionally, as the Company was formed on January 31, 2022 and has only a limited operating history and no earnings, the price of the offered shares is not based on its past earnings and no investment banker, appraiser or other independent third party has been consulted concerning the offering price for the shares or the fairness of the offering price used for the shares, as such our stockholders may not be able to receive a return on their investment when they sell their shares of common stock.
MONEY RAISED IN THIS OFFERING WILL BE IMMEDIATELY AVAILABLE TO THE COMPANY AND INVESTORS CANNOT WITHDRAW FUNDS ONCE INVESTED AND WILL NOT RECEIVE A REFUND.
Money raised in this offering will be immediately available to the company and our sole officer and director. Investors do not have the right to withdraw invested funds. Subscription payments will be paid directly to us and held on our corporate bank account if the Subscription Agreements are in good order and the Company accepts the subscription. Therefore, once an investment is made, investors will not have the use or right to return of such funds.
THERE IS NO GUARANTEE ALL OF THE FUNDS RAISED IN THE OFFERING WILL BE USED AS OUTLINED IN THIS PROSPECTUS.
We have committed to use the proceeds raised in this offering for the uses set forth in the “Use of Proceeds” section. However, certain factors beyond our control, such as increases in certain costs, could result in the Company being forced to reduce the proceeds allocated for other uses in order to accommodate these unforeseen changes. The failure of our management to use these funds effectively could result in unfavorable returns. This could have a significant adverse effect on our financial condition and could cause the price of our common stock to decline.
WE ARE SELLING THIS OFFERING WITHOUT AN UNDERWRITER AND MAY BE UNABLE TO SELL ANY SHARES.
This offering is self-underwritten, that is, we are not going to engage the services of an underwriter to sell the shares; we intend to sell our shares through our President, who will receive no commissions. There is no guarantee that he will be able to sell any of the shares. Unless he is successful in selling at 40% of the shares and we receive the proceeds in the amount of $840,000 of this offering, we may have to seek alternative financing to implement our business plan.
THE TRADING IN OUR SHARES WILL BE REGULATED BY THE SECURITIES AND EXCHANGE COMMISSION RULE 15G-9 WHICH ESTABLISHED THE DEFINITION OF A “PENNY STOCK.”
The shares being offered are defined as a penny stock under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), and rules of the Commission. The Exchange Act and such penny stock rules generally impose additional sales practice and disclosure requirements on broker-dealers who sell our securities to persons other than certain accredited investors who are, generally, institutions with assets in excess of $3,000,000 or individuals with a net worth in excess of $1,000,000 or annual income exceeding $200,000 ($300,000 jointly with spouse), or in transactions not recommended by the broker-dealer. For transactions covered by the penny stock rules, a broker dealer must make certain mandated disclosures in penny stock transactions, including the actual sale or purchase price and actual bid and offer quotations, the compensation to be received by the broker-dealer and certain associated persons, and deliver certain disclosures required by the Commission. Consequently, the penny stock rules may make it difficult for you to resell any shares you may purchase, if at all.
| 13 |
| Table of Contents |
DUE TO THE LACK OF A TRADING MARKET FOR OUR SECURITIES, YOU MAY HAVE DIFFICULTY SELLING ANY SHARES YOU PURCHASE IN THIS OFFERING.
We are not registered on any market or public stock exchange. There is presently no demand for our common stock and no public market exists for the shares being offered in this prospectus. We plan to contact a market maker immediately following the completion of the offering and apply to have the shares quoted on the OTC Pink Sheets (“OTC”) or other quotation service. The OTC is a regulated quotation service that displays real-time quotes, last sale prices and volume information in over-the-counter securities. The OTC is not an issuer listing service, market or exchange. Although the OTC does not have any listing requirements, to be eligible for quotation on the OTC, issuers must remain current in their filings with the SEC or applicable regulatory authority. If we are not able to pay the expenses associated with our reporting obligations we will not be able to apply for quotation on the OTC Pink Sheets or other quotation service. Market makers are not permitted to begin quotation of a security whose issuer does not meet this filing requirement. Securities already quoted on the OTC that become delinquent in their required filings will be removed following a 30-to-60-day grace period if they do not make their required filing during that time. We cannot guarantee that our application will be accepted or approved and our stock listed and quoted for sale. As of the date of this filing, there have been no discussions or understandings between Elements Ventures Group Inc. and anyone acting on our behalf, with any market maker regarding participation in a future trading market for our securities. If no market is ever developed for our common stock, or we do not sell sufficient shares or have sufficient shareholders to be quoted on the OTC, it will be difficult for you to sell any shares you purchase in this offering. In such a case, you may find that you are unable to achieve any benefit from your investment or liquidate, your shares without considerable delay, if at all. In addition, if we fail to have our common stock quoted on a public trading market, your common stock will not have a quantifiable value and it may be difficult, if not impossible, to ever resell your shares, resulting in an inability to realize any value from your investment.
WE WILL INCUR ONGOING COSTS AND EXPENSES FOR SEC REPORTING AND COMPLIANCE. WITHOUT REVENUE WE MAY NOT BE ABLE TO REMAIN IN COMPLIANCE, MAKING IT DIFFICULT FOR INVESTORS TO SELL THEIR SHARES, IF AT ALL.
The estimated cost of this registration statement is $25,000. We will have to utilize funds from Dmitry Kinslikh, our sole officer and director, who has verbally agreed to loan the company funds to complete the registration process. However, Mr. Dmitry Kinslikh has no obligation to loan such funds to us and there is a verbal guarantee that he will loan such funds to us. After the effective date of this prospectus, we will be required to file annual, quarterly and current reports, or other information with the SEC as provided by the Securities Exchange Act. We plan to contact a market maker immediately following the close of the offering and apply to have the shares quoted on the OTC Pink Sheets or other quotation service. To be eligible for quotation, issuers must remain current in their filings with the SEC. In order for us to remain in compliance we will require future revenues to cover the cost of these filings, which could comprise a substantial portion of our available cash resources. If we are unable to generate sufficient revenues to remain in compliance it may be difficult for you to resell any shares you may purchase, if at all. Also, if we are not able to pay the expenses associated with our reporting obligations we will not be able to apply for quotation on the OTC Pink Sheets or other quotation service.
THE ISSUANCE OF OUR SERIES A PREFERRED STOCK COULD RESULT IN SIGNIFICANT VOTING CONTROL AND DILUTION TO HOLDERS OF OUR COMMON STOCK.
Although no shares of our Series A Preferred Stock are currently issued or outstanding, we are authorized to issue Series A Preferred Stock in the future. Each share of Series A Preferred Stock is entitled to 10,000 votes and is convertible into 10,000 shares of our Common Stock. Accordingly, the issuance of Series A Preferred Stock could give its holders significant voting power and could substantially dilute the voting power and ownership interests of existing holders of our Common Stock. Depending on the number of shares issued and the concentration of ownership, holders of Series A Preferred Stock could exercise significant influence or control over matters submitted to our shareholders.
In addition, while any Series A Preferred Stock is outstanding, certain corporate actions require the affirmative vote of at least 67% of the outstanding Series A Preferred Stock voting separately as a class. These rights could allow holders of Series A Preferred Stock to prevent or delay certain corporate actions that holders of our Common Stock may consider desirable.
| 14 |
| Table of Contents |
Our Series A Preferred Stock is convertible at a ratio of 10,000 shares of Common Stock for each share of Series A Preferred Stock. If all authorized Series A Preferred Stock were issued and converted, the number of shares of Common Stock required upon conversion could exceed our currently authorized 500,000,000 shares of Common Stock. We therefore could not satisfy such conversions in full unless sufficient authorized and unissued shares of Common Stock were available. We would need to increase the number of our authorized shares of Common Stock in accordance with applicable law and our governing documents before any conversion requiring shares in excess of our then-authorized and available Common Stock could be completed. Any such increase and subsequent issuance of Common Stock upon conversion could result in substantial dilution to existing holders of our Common Stock.
Our public offering of 6,000,000 shares is being made at a price per share is $0.35 with net proceeds of $2,075,000 after estimated offering expenses of $25,000. The following table sets forth the uses of proceeds assuming the sale of 25%, 50%, 75% and 100%, respectively, of the securities offered for sale by the Company. There is no assurance that we will raise the full $2,100,000 as anticipated.
|
|
| 25% of Offering Sold |
|
| 50% of Offering Sold |
|
| 75% of Offering Sold |
|
| 100% of Offering Sold |
| ||||
| Gross Proceeds from this Offering (1) |
| $ | 525,000 |
|
| $ | 1,050,000 |
|
| $ | 1,575,000 |
|
| $ | 2,100,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares Sold |
|
| 1,500,000 |
|
|
| 3,000,000 |
|
|
| 4,500,000 |
|
|
| 6,000,000 |
|
| Gross Proceeds |
| $ | 525,000 |
|
| $ | 1,050,000 |
|
| $ | 1,575,000 |
|
| $ | 2,100,000 |
|
| Total Before Expenses |
| $ | 525,000 |
|
| $ | 1,050,000 |
|
| $ | 1,575,000 |
|
| $ | 2,100,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Administrative Offering Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal & Accounting |
| $ | 20,000 |
|
| $ | 20,000 |
|
| $ | 20,000 |
|
| $ | 20,000 |
|
| Publishing/EDGAR |
| $ | 2,000 |
|
| $ | 2,000 |
|
| $ | 2,000 |
|
| $ | 2,000 |
|
| Transfer Agent |
| $ | 2,000 |
|
| $ | 2,000 |
|
| $ | 2,000 |
|
| $ | 2,000 |
|
| SEC Filing Fee |
| $ | 406.55 |
|
| $ | 406.55 |
|
| $ | 406.55 |
|
| $ | 406.55 |
|
| Miscellaneous |
| $ | 593.45 |
|
| $ | 593.45 |
|
| $ | 593.45 |
|
| $ | 593.45 |
|
| Total Administrative Operating Expenses |
| $ | 25,000 |
|
| $ | 25,000 |
|
| $ | 25,000 |
|
| $ | 25,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net Offering Proceeds |
| $ | 500,000 |
|
| $ | 1,025,000 |
|
| $ | 1,550,000 |
|
| $ | 2,075,000 |
|
| Use of Net Proceeds |
|
|
|
|
|
|
|
|
|
|
|
| ||||
| Product deployment, launch & development |
| $ | 143,000 |
|
| $ | 293,150 |
|
| $ | 443,300 |
|
| $ | 593,450 |
|
| Personnel |
| $ | 107,000 |
|
| $ | 219,350 |
|
| $ | 331,700 |
|
| $ | 444,050 |
|
| Sales & business development |
| $ | 71,500 |
|
| $ | 146,575 |
|
| $ | 221,650 |
|
| $ | 296,725 |
|
| Marketing & user acquisition |
| $ | 59,500 |
|
| $ | 121,975 |
|
| $ | 184,450 |
|
| $ | 246,925 |
|
| Third-party services & infrastructure |
| $ | 35,500 |
|
| $ | 72,775 |
|
| $ | 110,050 |
|
| $ | 147,325 |
|
| Strategic cash reserves |
| $ | 59,500 |
|
| $ | 121,975 |
|
| $ | 184,450 |
|
| $ | 246,925 |
|
| General & administrative expense |
| $ | 24,000 |
|
| $ | 49,200 |
|
| $ | 74,400 |
|
| $ | 99,600 |
|
| Total |
| $ | 500,000 |
|
| $ | 1,025,000 |
|
| $ | 1,550,000 |
|
| $ | 2,075,000 |
|
We believe the net proceeds from the sale of all the shares we are offering, assuming all the shares are sold (of which you have no assurance), will be sufficient to fund our operational expansion goals assuming application of the proceeds as outlined above. See “Plan of Operations”. The board of directors reserves the right to reallocate the use of net proceeds, if, in its judgment, such reallocation will best serve its needs in meeting changes, developments and unforeseen delays and difficulties. Pending use, the net proceeds shall be invested in certificates of deposit, money market accounts, treasury bills, and similar short term, liquid investments with substantial safety of principal. We will not use any of the funds raised in this offering to repay any amounts due to our sole officer and director Dmitry Kinslikh.
| 15 |
| Table of Contents |
Determination of Offering Price
We determined the offering price of $0.35 per share for the shares offered in this prospectus. In establishing the offering price, we considered a number of factors, including our current stage of development, our business prospects, our anticipated financing needs, the amount of capital we seek to raise, our limited operating history and the absence of an established public trading market for our Common Stock. The $0.35 offering price was determined by us and is not based on an independent valuation of our Common Stock. The offering price does not necessarily bear any relationship to our assets, book value, revenues, earnings, historical results, financial condition or any other established measure of value. The $0.35 offering price also bears no direct relationship to the prices previously paid for shares of our Common Stock by our existing shareholders. Those prior issuances occurred at different times and under different circumstances and were not used as the basis for determining the offering price.
In addition, our most recent convertible note provides for conversion into Common Stock at $0.015 per share. The $0.35 offering price is substantially higher than this conversion price. The $0.015 conversion price was separately negotiated in connection with the financing represented by that note and was not used as a basis for determining the offering price in these offerings.
Accordingly, the $0.35 offering price should not be considered an indication of the actual value of our Common Stock or the price at which our Common Stock may trade, if a trading market develops. There can be no assurance that our Common Stock will trade at or above the $0.35 offering price following the offering.
DILUTION
The price of the current offering is fixed at $0.35 per share. This price is significantly higher than the valuation of the shares issued to our sole officer and director, Dmitry Kinslikh, which was $0.0001 per share for the 7,000,000 shares of common stock he purchased from the Company. In addition, we have issued 4,817,167 shares to a number of shareholders at varying prices. We also have issued various convertible notes which are convertible into 2,533,333 shares of our common stock.
Dilution represents the difference between the offering price and the net tangible book value per share immediately after completion of this offering. Net tangible book value is the amount that results from subtracting total liabilities and intangible assets from total assets. Dilution arises mainly as a result of our arbitrary determination of the offering price of shares being offered. Dilution of the value of the shares you purchase is also a result of the lower book value of the shares held by our existing stockholders. The following tables compare the differences of your investment in our shares with the investment of our existing stockholders.
|
|
| Offering (100%) |
|
| Offering (75%) |
|
| Offering (50%) |
|
| Offering (25%) |
| ||||
| Number of current shares held |
|
| 11,817,167 |
|
|
| 11,817,167 |
|
|
| 11,817,167 |
|
|
| 11,817,167 |
|
| Number of new shares issued |
|
| 6,000,000 |
|
|
| 4,500,000 |
|
|
| 3,000,000 |
|
|
| 1,500,000 |
|
| Total number of new shares held |
|
| 17,817,167 |
|
|
| 16,317,167 |
|
|
| 14,817,167 |
|
|
| 13,317,167 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net tangible book value before this offering |
| $ | (94,521 | ) |
| $ | (94,521 | ) |
| $ | (94,521 | ) |
| $ | (94,521 | ) |
| Net proceeds to the company |
| $ | 2,075,000 |
|
| $ | 1,550,000 |
|
| $ | 1,025,000 |
|
| $ | 500,000 |
|
| Net tangible book value after this offering |
| $ | 1,980,479 |
|
| $ | 1,455,479 |
|
| $ | 930,479 |
|
| $ | 405,479 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Assumed public offering price per share |
| $ | 0.35 |
|
| $ | 0.35 |
|
| $ | 0.35 |
|
| $ | 0.35 |
|
| Net tangible book value per share before this offering |
| $ | (0.0080 | ) |
| $ | (0.0080 | ) |
| $ | (0.0080 | ) |
| $ | (0.0080 | ) |
| Increase attributable to new investors |
| $ | 0.1192 |
|
| $ | 0.097 |
|
| $ | 0.071 |
|
| $ | 0.038 |
|
| Net tangible book value per share after this offering |
| $ | 0.1112 |
|
| $ | 0.089 |
|
| $ | 0.063 |
|
| $ | 0.030 |
|
| Dilution per share to new stockholders |
| $ | 0.2388 |
|
| $ | 0.261 |
|
| $ | 0.287 |
|
| $ | 0.320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Current Shareholders % after offering |
|
| 66 |
|
|
| 72 |
|
|
| 80 |
|
|
| 89 | % |
| Purchasers % after offering |
|
| 34 |
|
|
| 28 |
|
|
| 20 |
|
|
| 11 | % |
As of May 31, 2026, the net tangible book value was $(94,521) or $(0.0080) based upon 11,817,167 shares outstanding.
| 16 |
| Table of Contents |
The selling shareholders named in this prospectus are offering all of the 4,817,167 shares of common stock offered for resale through this prospectus.. The 4,817,167 shares that were previously issued were acquired from us in private placements that were exempt from registration provided under Regulation S of the Securities Act of 1933. All of the sales/issuances of the stock were made to non-U.S. persons (as defined under Rule 902 section (k)(2)(i) of Regulation S), pursuant to offshore transactions, and no directed selling efforts were made in the United States by the issuer, a distributor, any of their respective affiliates, or any person acting on behalf of any of the foregoing.
The following table provides as of the date of this prospectus, information regarding the beneficial ownership of our common stock held by each of the selling shareholders, including:
|
| · | the number of shares owned by each prior to this offering; |
|
|
|
|
|
| · | the total number of shares that are to be offered for each; |
|
|
|
|
|
| · | the total number of shares that will be owned by each upon completion of the offering; and |
|
|
|
|
|
| · | the percentage owned by each upon completion of the offering. |
| Name Of Selling Shareholder |
| Shares Owned Prior To This Offering |
|
| Total Number of Shares to Be Offered For Selling Shareholders Account |
|
| Total Shares to Be Owned Upon Completion Of This Offering |
| Percentage of Shares owned Upon Completion of This Offering | |||
| Lana Adamson |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Deepti Agarwal |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Rajeev Agarwal |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Muhammed Ajram |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Bhupinder Brar |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Komaljit Brar |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Amrit Singh Chahal |
|
| 10,000 |
|
|
| 10,000 |
|
| Nil |
| Nil |
|
| Jasmeet Chahal |
|
| 10,000 |
|
|
| 10,000 |
|
| Nil |
| Nil |
|
| El Toro Capital Build (1) |
|
| 26,667 |
|
|
| 26,667 |
|
| Nil |
| Nil |
|
| Sergey Fedotov |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Jagdeep Gill |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Jasbir Gill |
|
| 500,000 |
|
|
| 500,000 |
|
| Nil |
| Nil |
|
| Jaswinder Gill |
|
| 500,000 |
|
|
| 500,000 |
|
| Nil |
| Nil |
|
| Tejpal Gill |
|
| 500,000 |
|
|
| 500,000 |
|
| Nil |
| Nil |
|
| Manjinder Kalirai |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Navdeep Kalirai |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Parlad Kalirai |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Ramandeep Kalirai |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Izrael Kinslikh |
|
| 500,000 |
|
|
| 500,000 |
|
| Nil |
| Nil |
|
| Balwinder Kooner |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Gurjeet Kooner |
|
| 500,000 |
|
|
| 500,000 |
|
| Nil |
| Nil |
|
| Daniel Kostin |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Sergey Sukhanov |
|
| 10,000 |
|
|
| 10,000 |
|
| Nil |
| Nil |
|
| Rahul Maingi |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Julia Milter |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Sergey Milter |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Jaskarn Rai |
|
| 500,000 |
|
|
| 500,000 |
|
| Nil |
| Nil |
|
| Teresa Safarian |
|
| 10,000 |
|
|
| 10,000 |
|
| Nil |
| Nil |
|
| Mehnoor Sandhu |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Neeti Prabhjot Sandhu |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Jaspreet Saran |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Grace Sharma |
|
| 500,000 |
|
|
| 500,000 |
|
| Nil |
| Nil |
|
| Vladimir Sidelnikov |
|
| 500 |
|
|
| 500 |
|
| Nil |
| Nil |
|
| Simarpreet Singh |
|
| 10,000 |
|
|
| 10,000 |
|
| Nil |
| Nil |
|
| Vladimir Yevdokimov |
|
| 10,000 |
|
|
| 10,000 |
|
| Nil |
| Nil |
|
| Elena Znamenskaya (2) |
|
| 520,000 |
|
|
| 520,000 |
|
| Nil |
| Nil |
|
| Roman Znamenski |
|
| 700,000 |
|
|
| 700,000 |
|
| Nil |
| Nil | |
|
| (1) | Marlis Guerra has voting and investment control over shares held by El Toro Capital Build. |
|
| (2) | Includes 20,000 shares held by Capitale Matador Ltee. |
| 17 |
| Table of Contents |
By Selling Stockholders
In connection with the sale of the common shares, agents may receive compensation from the selling stockholders or from purchasers of common shares for whom they may act as agents in the form of discounts, concessions or commissions. The selling shareholders named herein may be deemed underwriters of the shares of common stock which they are offering and any profit on the resale of the common shares by them may be deemed to be underwriting discounts or commissions under such Act. We will not receive any proceeds from sale of shares by selling stockholders.
Upon our being notified by a selling stockholder that any material arrangement has been entered into with a broker or dealer for the sale of any common shares other than through a stockholders brokerage account a Prospectus supplement or post-effective amendment will be filed, if required, pursuant to Rule 424(b) under the Securities Act of 1933
By Us
We are offering up to 6,000,000 shares of common stock on a direct public offering, without any involvement of underwriters or broker-dealers, no minimum. The offering price is $0.35 per share at a fixed price for the duration of the offering. This prospectus will permit our sole officer and director to sell the shares directly to the public, with no commission or other remuneration payable to him for any shares that they may sell. Our officer and director will sell the shares and intends to offer them to friends, family members and business acquaintances. The shares will be offered at a fixed price of $0.35 per share for a period of 365 days from the effective date of this prospectus, unless extended by our board of directors for an additional 90 days. Our board may choose to extend the offering for an additional 90 days if all of the shares are not sold at the end of 365 days from the effective date of this prospectus. The same periods apply to the selling stockholders named in this prospectus who will also be selling their shares at a fixed price of $0.35 per share.
Our subscription agreement allows purchasers to purchase shares from us and requires that we promptly deliver the shares in book entry unless a certificate is requested, representing the Shares, registered in the name of the Purchaser.
We have 11,817,167 shares of common stock issued and outstanding as of the date of this prospectus. The Company is registering 6,000,000 shares of its common stock for sale at the price of $0.35 per share. There is no arrangement to address the possible effect of the offering on the price of the stock. In connection with the Company’s selling efforts in the offering, Dmitry Kinslikh will not register as a broker-dealer pursuant to Section 15 of the Exchange Act, but rather will rely upon the “safe harbor” provisions of SEC Rule 3a4-1, promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Rule 3a4-1 provides an exemption from the broker-dealer registration requirements of the Exchange Act for persons associated with an issuer that participate in an offering of the issuer’s securities.
Dmitry Kinslikh is not subject to any statutory disqualification, as that term is defined in Section 3(a)(39) of the Exchange Act. Dmitry Kinslikh will not be compensated in connection with his participation in the offering by the payment of commissions or other remuneration based either directly or indirectly on transactions in our securities. Dmitry Kinslikh is not, and has not been within the past 12 months, a broker or dealer, and he has not been within the past 12 months, an associated person of a broker or dealer. At the end of the offering, Dmitry Kinslikh will continue to primarily perform substantial duties for the Company or on its behalf otherwise than in connection with transactions in securities. Dmitry Kinslikh will not participate in selling an offering of securities for any issuer more than once every 12 months other than in reliance on Exchange Act Rule 3a4-1(a)(4)(i) or (iii).
| 18 |
| Table of Contents |
We will receive all proceeds from the sale of the 6,000,000 shares being offered. The price per share is fixed at $0.35 for the duration of this offering. Although our common stock is not listed on a public exchange or other quotation service, we intend to seek to have our shares of common stock quoted on the OTC Pink Sheets or other quotation service. In order to be quoted on the OTC Pink Sheets or other quotation service, a market maker must file an application on our behalf in order to make a market for our common stock. There can be no assurance that a market maker will agree to file the necessary documents with FINRA, nor can there be any assurance that such an application for quotation will be approved.
The Company’s shares may be sold to purchasers from time to time directly by and subject to the discretion of the Company. Further, the Company will not offer its shares for sale through underwriters, dealers, agents or anyone who may receive compensation in the form of underwriting discounts, concessions or commissions from the Company and/or the purchasers of the shares for whom they may act as agents. The shares of common stock sold by the Company may be occasionally sold in one or more transactions; all shares sold under this prospectus will be sold at a fixed price of $0.35 per share.
In order to comply with the applicable securities laws of certain states, the securities will be offered or sold in those only if they have been registered or qualified for sale; an exemption from such registration or if qualification requirement is available and with which we have complied. In addition, and without limiting the foregoing, we will be subject to applicable provisions, rules and regulations under the Exchange Act with regard to security transactions during the period of time when this Registration Statement is effective. We will pay all expenses incidental to the registration of the shares (including registration pursuant to the securities laws of certain states).
| 19 |
| Table of Contents |
General
There is no established public trading market for our common stock. Our authorized capital stock consists of 500,000,000 shares of common stock, $0.0001 par value per share and 20,000,000 shares of preferred stock, par value $0.0001 per share. As of May 31, 2026 there were 11,817,167 shares of our common stock issued and outstanding that are held by our shareholders, and no shares of preferred stock are issued and outstanding. If all authorized Series A Preferred Stock were issued and converted, the number of shares of Common Stock required upon conversion could exceed our current authorization of 500,000,000 shares of Common Stock. Because no Series A Preferred Stock is currently outstanding, we have no current obligation to issue shares of Common Stock upon conversion. If we were to issue Series A Preferred Stock in an amount requiring more Common Stock upon conversion than we then have authorized and available for issuance, we would need to increase our authorized Common Stock in accordance with applicable law and our governing documents before we could satisfy such conversion in full.
Common Stock
The holders of our common stock currently have (i) equal ratable rights to dividends from funds legally available therefore, when, as and if declared by the Board of Director of the Company; (ii) are entitled to share ratably in all of the assets of the Company available for distribution to holders of common stock upon liquidation, dissolution or winding up of the affairs of the Company (iii) do not have pre-emptive, subscription or conversion rights and there are no redemption or sinking fund provisions or rights applicable thereto; and (iv) are entitled to one non- cumulative vote per share on all matters on which stock holders may vote.
Convertible Stock
We have issued five convertible promissory notes, each convertible at the option of the holder at $0.015 per share: a $5,000 note dated November 24, 2023 (333,333 shares); a $6,000 note dated April 1, 2024 (400,000 shares); a $9,000 note dated August 27, 2025 (600,000 shares); a $3,000 note dated November 14, 2025 (200,000 shares); and a $15,000 note dated May 29, 2026 (1,000,000 shares). An aggregate of 2,533,333 shares of common stock are issuable upon conversion of all five notes.
Holders
As of June 29, 2026, we had had 40 holders of record.
Dividend Policy
We have not declared or paid dividends on our common stock since our formation, and we do not anticipate paying dividends in the foreseeable future. Declaration or payment of dividends, if any, in the future, will be at the discretion of our Board of Directors and will depend on our then current financial condition, results of operations, capital requirements and other factors deemed relevant by the Board of Directors. There are no contractual restrictions on our ability to declare or pay dividends.
Transfer Agent
We have not retained a transfer agent to serve as transfer agent for shares of our common stock. Until we engage such a transfer agent, we will be responsible for all record-keeping and administrative functions in connection with the shares of our common stock.
Penny Stock Rules
The Securities Exchange Commission has also adopted rules that regulate broker-dealer practices in connection with transactions in “penny stocks” as such term is defined by Rule 15g-9. Penny stocks are generally equity securities with a price of less than $5.00 (other than securities registered on certain national securities exchanges or provided that current price and volume information with respect to transactions in such securities is provided by the exchange).
The shares offered by this prospectus constitute penny stock under the Securities and Exchange Act. The shares will remain penny stock for the foreseeable future. The classification of penny stock makes it more difficult for a broker-dealer to sell the stock into a secondary market, which makes it more difficult for a purchaser to liquidate his or her investment. Any broker-dealer engaged by the purchaser for the purpose of selling his or her shares in our company will be subject to the penny stock rules.
| 20 |
| Table of Contents |
The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from those rules, deliver a standardized risk disclosure document prepared by the Commission, which: (i) contains a description of the nature and level of risk in the market for penny stocks in both public offerings and secondary trading; (ii) contains a description of the broker’s or dealer’s duties to the customer and of the rights and remedies available to the customer with respect to a violation to such duties or other requirements of Securities’ laws; (iii) contains a brief, clear, narrative description of a dealer market, including bid and ask prices for penny stocks and significance of the spread between the bid and ask price; (iv) contains a toll-free telephone number for inquiries on disciplinary actions; (v) defines significant terms in the disclosure document or in the conduct of trading in penny stocks; and (vi) contains such other information and is in such form as the Commission shall require by rule or regulation. The broker-dealer also must provide to the customer, prior to effecting any transaction in a penny stock, (i) bid and offer quotations for the penny stock; (ii) the compensation of the broker-dealer and its salesperson in the transaction; (iii) the number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the market for such stock; and (iv) monthly account statements showing the market value of each penny stock held in the customer’s account.
In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from those rules; the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written acknowledgment of the receipt of a risk disclosure statement, a written agreement to transactions involving penny stocks, and a signed and dated copy of a written suitability statement. These disclosure requirements will have the effect of reducing the trading activity in the secondary market for our stock because it will be subject to these penny stock rules. Therefore, stockholders may have difficulty selling those securities.
Overview
We are a development-stage consumer-wellness company. Our business is the development and intended commercialization of FITLY, a consumer mobile application for general health and wellness, together with a related web-based dashboard intended for employers and health plans.
What FITLY Is
FITLY is designed to help everyday users pursue general fitness, nutrition, and healthy-lifestyle goals through a single, guided mobile experience. Rather than requiring a user to assemble their own plan, FITLY provides structure: a guided onboarding that captures the user’s goals and wellness profile, a set of multi-week wellness programs with daily tasks, day-to- tracking of meals and activity, and an assistive conversational coaching feature. The application remembers the user’s profile and progress and uses that context to make its guidance relevant to the individual over time.
FITLY consists of two parts:
|
| · | a consumer mobile application for iOS and Android, organized into four areas — AI Coach, Nutrition, Progress, and Profile; and |
|
| · | a web-based administrative dashboard intended to allow an employer or health plan that elects to offer FITLY to its population to manage access and view aggregated, anonymized engagement information. |
| 21 |
| Table of Contents |
Why FITLY, and not a general-purpose tool
The assistive conversational feature in FITLY is powered by a third-party artificial-intelligence service, and general-purpose AI assistants are widely available. We believe FITLY’s value to a user is the structure and product experience built around that capability: a guided onboarding and wellness profile; structured, multi-week programs with specific daily tasks; persistent tracking of meals, activity, and progress; specialized features such as photo-based meal logging and barcode lookup; and, for organizations, a deployable dashboard with aggregated reporting. Most people do not want to assemble their own wellness program from a blank, general-purpose tool; FITLY is designed to provide that structure in a single guided product. The competitive considerations associated with general-purpose tools and other applications are described under “Risk Factors.”
The Application, Feature by Feature
The following describes the principal features of the FITLY mobile application. Except where a feature is identified as planned (a documented next step not yet implemented), the features described are built and functional in our codebase. As noted under “Overview” and “Development Status and Path to Launch,” the application as a whole has not yet been deployed to production or released to the app stores.
The screen images shown in this section are illustrative mockups of the application’s design and are not screenshots of a live product.
Account creation and onboarding
A new user creates an account and completes a five-step onboarding wizard that captures the information FITLY uses to personalize guidance: wellness goals (for example, weight management, building strength, general health, endurance, flexibility, stress reduction, blood-sugar wellness, post-physical-therapy recovery, better sleep, and healthier eating); self-described fitness level; a wellness profile; available equipment; and preferred workout length and weekly frequency. Each step is saved before the user proceeds, so onboarding can be resumed if interrupted. Throughout, the application presents a wellness disclaimer advising the user to consult a healthcare provider before beginning a program, particularly if the user has a pre-existing condition.
| 22 |
| Table of Contents |

AI Coach (assistive conversational coaching)
The AI Coach is a chat-style feature in which the user can ask general wellness questions and receive conversational guidance. The interface presents a conversation thread, a typing indicator while a response is being generated, an input field, and a row of quick actions (for example, requesting a workout idea or reviewing progress). A first conversation is created automatically with a welcome message, and the user’s profile and history provide context for responses.
The coaching responses are generated by a third-party AI service (the Anthropic Claude API). We do not develop, train, fine-tune, or host any AI models; the feature depends entirely on the third-party provider, under that provider’s standard commercial terms. The coaching feature operates under a fixed set of safety instructions designed to keep it within a general-wellness boundary — it is instructed not to act as a medical professional, not to diagnose or prescribe, to recommend consulting a healthcare provider, and to provide emergency-stop guidance in response to certain symptoms. On the free tier, the number of coaching messages per day is limited; paid tiers remove that limit.
| 23 |
| Table of Contents |

Nutrition tracking
The Nutrition area lets a user track meals and daily nutrition. It presents daily totals for calories and macronutrients against optional targets, the remaining calorie budget for the day, and a list of the day’s logged meals. A user can add a meal in several built ways:
|
| · | Photo logging (“Snap & Scan”): the user photographs a meal (or selects an existing photo), and the image is analyzed to identify foods and estimate nutrition. The image analysis is performed by the third-party AI service. |
|
| · | Barcode lookup: the user scans a packaged-food barcode, which is matched against a public, third-party food-product database (Open Food Facts). |
|
| · | Manual meal entry: the user can add a meal without a photo or barcode, entering one or more foods with serving and nutrition values; the meal is saved and reflected in the day’s totals and meal list. |
|
| · | Meal-correction editing: the user can edit the results of a photo analysis — adjusting identified foods, servings, and nutrition values — and the corrected values persist and update the daily totals. |
| 24 |
| Table of Contents |

Progress tracking
The Progress area shows the user’s current activity streak, a recovery-score indicator, and trends across wellness metrics (such as steps, resting heart rate, sleep, weight, mood, and energy) over selectable time periods, presented as rendered line charts with numeric summary statistics, along with brief insights. A user can also manage a connection to a wearable device.
The application includes the interface to connect a wearable device and the backend to receive wearable data; native device-data capture on the phone (Apple Health / Health Connect) is not yet implemented and remains planned, so real device biometrics do not yet flow into the system. Manual entry is the working path for biometric data until that integration is completed.
| 25 |
| Table of Contents |

Structured wellness programs
FITLY includes five structured, multi-week wellness programs, described in detail under “Wellness Programs” below. A user can browse the programs, enroll, complete daily tasks, mark progress, and advance week to week. One program is available on the free tier; the others are available on the paid tiers.
| 26 |
| Table of Contents |

Profile and subscription
The Profile area shows the user’s account, current subscription plan and price, an in-app status panel describing feature status, and access to the programs and account settings. The secondary screens are built: the user can edit their profile (fitness level, goals, wellness profile, equipment, and schedule, which persist server-side), manage wearable-device connections (connection management; native device-data capture remains planned, as noted above), and set notification preferences (which persist on the device; actual push-notification delivery is not yet enabled).
Web administrative dashboard (employer / health-plan)
Separately from the consumer app, we have built a web-based administrative dashboard intended for an employer or health plan that elects to offer FITLY to its population. It provides an administrator login and company setup, aggregated and anonymized engagement metrics (such as enrolled and active participants, engagement rate, and aggregate activity counts), employee-invitation tools (including bulk invitation and a shareable join link), and the ability to create wellness challenges. The dashboard repeatedly states that individual employee health data is never visible and that all data is anonymized and aggregated. Certain enterprise configuration items (for example, single-sign-on provider selection) capture configuration only; the underlying single-sign-on authentication handshake is not yet implemented.
| 27 |
| Table of Contents |

Summary of features and status
| Feature | What it does | Status |
| Account & onboarding | Sign-up and a five-step wellness-profile wizard | Built |
| AI Coach | Assistive conversational wellness guidance (third-party AI) | Built (live AI integration not yet configured) |
| Photo meal logging (“Snap & Scan”) | Identifies foods and estimates nutrition from a photo (third-party AI) | Built (live AI integration not yet configured) |
| Barcode lookup | Matches packaged foods via a public food database | Built |
| Daily nutrition tracking | Calorie/macro totals against targets | Built |
| Manual meal entry | Enter a meal without a photo or barcode | Built |
| Meal-correction editing | Edit photo-analysis results in detail | Built |
| Progress tracking | Streak, recovery score, metric trends, insights | Built |
| Progress charts | Rendered line charts of metric trends | Built |
| Wearable connection | Manage a wearable connection | Built |
| Wearable native device-data capture | Read biometrics from the device’s health platform | Planned (not implemented) |
| Structured programs | Enroll, complete daily tasks, advance weekly | Built |
| Subscription management | View plan, upgrade via in-app paywall | Built (billing disabled pending setup) |
| Profile — edit profile | Edit goals, fitness level, profile, equipment, schedule | Built |
| Profile — notification preferences | Set reminders (saved on device; push delivery not yet enabled) | Built |
| Web administrative dashboard | Employer/health-plan management and aggregate analytics | Built |
| Enterprise single sign-on | SSO authentication for administrators | Planned (config capture only) |
| Secure communication with wellness professionals | Private exchange of messages, files, and images | Planned (separate, not integrated) |
| 28 |
| Table of Contents |
How a User Uses FITLY
The intended user experience follows a simple sequence:
|
| 1. | Acquire the application (planned — FITLY is not yet available in any app store). |
|
| 2. | Create an account (or sign in). |
|
| 3. | Complete onboarding — goals, fitness level, wellness profile, equipment, and schedule. |
|
| 4. | Arrive in the four-area app, where a first AI Coach conversation is created automatically. |
|
| 5. | Use FITLY day to day — ask the AI Coach questions; log meals by photo or barcode and track daily nutrition; review progress, streaks, and trends; enroll in and work through a structured program; and manage the account and subscription from the Profile area. |
|
| 6. | Upgrade, if desired, from the free tier to Plus or Pro through the in-app subscription screen. |

Wellness Programs
FITLY includes five structured, multi-week general-wellness programs, built from five task types — workout, nutrition, education, check-in, and rest. Across all five programs there are 32 weeks and 247 daily tasks. Each program consists of general lifestyle and wellness content; none diagnoses, treats, cures, or prevents any disease, and the programs are accompanied by wellness disclaimers.
| # | Program | Focus (general wellness) | Weeks | Availability |
| 1 | Healthy Lifestyle for Blood Sugar Wellness | Progressive walking, gentle bodyweight activity, nutrition-awareness habits | 8 | Free (all tiers) |
| 2 | Beginner Fitness Foundation | Movement basics, light circuits, easy walks | 4 | Paid |
| 3 | Walk-to-Run Progression | Graduated walk-to-run intervals | 6 | Paid |
| 4 | Post-Physical-Therapy Recovery | Graduated strength and mobility for returning to activity | 6 | Paid |
| 5 | Strength Building Foundation | Progressive strength work | 8 | Paid |
General-wellness and risk-reduction framing. Consistent with FDA guidance applicable to low-risk general wellness products, certain of our programs and content refer to general health goals — such as blood-sugar wellness, healthy blood pressure, and recovery of general fitness following physical therapy — using healthy-lifestyle and risk-reduction language rather than disease treatment or prevention claims. For example, the Healthy Lifestyle for Blood Sugar Wellness program describes how healthy lifestyle choices may help reduce the risk of developing certain conditions as part of a balanced approach to wellness, in partnership with the user’s healthcare provider. The program does not instruct on medication, dosing, laboratory interpretation, or clinical management.
| 29 |
| Table of Contents |
The CDC-aligned program. The Healthy Lifestyle for Blood Sugar Wellness program is aligned with publicly available CDC lifestyle-change curriculum guidelines, meaning its general structure follows publicly available curriculum guidance. We have not received any recognition from the CDC, we do not participate in any CDC program, and we have no clinical, efficacy, or outcomes data of any kind. “Aligned with” does not mean endorsed, reviewed, or recognized by the CDC.
FITLY is a general-wellness product. It does not diagnose, treat, cure, or prevent any disease or medical condition; it is not a medical device; and it is not a substitute for professional medical advice, diagnosis, or treatment. Users are advised to consult a healthcare provider, particularly before beginning a program or if they have a pre-existing condition. See “Risk Factors” and “Government Regulation.”
Technology
FITLY is built using standard, widely available software frameworks and third-party services. We do not own or operate any proprietary core technology that we consider a competitive barrier, and we do not develop, train, or host any artificial-intelligence models.
Application architecture. The consumer application is built with React Native (using the Expo toolchain) for iOS and Android. The backend is a Node.js service using the Express framework, with a PostgreSQL database organized as a 23-table data model and a Redis-backed background worker for routine processing. The administrative dashboard is a web application built with React. The application stores user accounts, profiles, conversations, logged meals and nutrition, progress entries, program enrollments, and (for organizations) aggregated enterprise analytics.
Artificial intelligence. The assistive features that use artificial intelligence — the conversational coaching and the photo-based meal analysis — call a single third-party AI service, the Anthropic Claude API, under that provider’s standard commercial terms. We use a single AI provider and do not operate any model-routing or multi-provider layer. We do not own, train, fine-tune, or host any AI models, and we have no proprietary AI technology. The feature depends entirely on the third-party provider’s service, pricing, availability, and terms, and as of the date of this prospectus our integration has been written in our code but has not been tested against the provider’s live production systems.
Other third-party services. FITLY is built to use additional third-party services, in each case under those providers’ standard commercial terms: a public food-product database (Open Food Facts) for barcode lookups; a subscription-billing service (RevenueCat) for in-app subscriptions; and error-monitoring and product-analytics services (Sentry and PostHog). As of the date of this prospectus, the billing, error-monitoring, and analytics services are coded but not yet enabled with live credentials. We have no exclusive or proprietary arrangement with any of these providers.
| Technology summary |
|
| Mobile application | React Native / Expo (iOS and Android) |
| Backend | Node.js (Express), PostgreSQL, Redis background worker |
| Administrative dashboard | React (web) |
| Artificial intelligence | Anthropic Claude API (third-party; no owned models) |
| Other third-party services | Open Food Facts (food database); RevenueCat (billing); Sentry, PostHog (monitoring/analytics) |
| Proprietary technology | None claimed |
Secure communication capability (planned). Separately from the FITLY application, we have developed software that supports secure, encrypted communication, which we may incorporate into FITLY in the future to allow a user to exchange private messages and shared content — such as files, documents, or images — with a wellness professional, such as a nutritionist, dietitian, or personal trainer, within the application. For example, a user could privately share a meal photo, a progress summary, or a workout log with their chosen professional and receive guidance in return. This software represents additional development work we have undertaken and is part of our development assets. It is licensed under a permissive open-source license, is not currently integrated into FITLY, and is a planned future capability.
| 30 |
| Table of Contents |
Development Status and Path to Launch
Our codebase comprises approximately 101 application files and roughly 15,400 lines of code across the mobile application, backend, and administrative dashboard, and has passed our internal quality-assurance review. We have built a substantially complete consumer application and a related administrative dashboard, with a defined product, target market, and intended revenue model — work that we believe clearly distinguishes us from a company without a business.
The application has not yet been deployed to production or released to the Apple App Store or Google Play Store, and it has no users and no revenue. Live integration credentials (for the AI provider, billing, and monitoring and analytics services) are not yet configured, and certain features remain planned (including native wearable device-data capture, push-notification delivery, and enterprise single sign-on). The remaining work to bring FITLY to market is set out below.
Before FITLY can be made available to users, we must, among other things:
|
| 1. | finalize and configure our third-party service integrations (including the AI provider and the billing, monitoring, and analytics services) and test them against live systems; |
|
| 2. | complete the planned features we determine are necessary for our initial launch scope (which may include the native wearable device-data capture, push-notification delivery, and enterprise single sign-on); |
|
| 3. | provision and deploy production hosting for the backend, worker, database, and dashboard, and run database setup; |
|
| 4. | prepare and submit the mobile application to the Apple App Store and Google Play Store (including testing builds), and obtain each store’s approval; and |
|
| 5. | commence operations and initial, measured user-acquisition activity. |
We intend to fund these steps, and our subsequent operations, with the net proceeds of this offering. See “Use of Proceeds.” There is no assurance that we will complete these steps, obtain app-store approvals, or successfully launch the application.

Intended Market and Business Model
We believe the market for consumer health-and-wellness applications is large, established, and highly competitive, and includes numerous well-funded companies. We intend to offer FITLY first to consumers through the mobile app stores on a freemium subscription basis, and over time to offer it to employers and health plans through the administrative dashboard we have developed. We currently have no agreements, pilots, or relationships with any consumers, employers, health plans, or other organizations, and there is no assurance that we will obtain any.
| 31 |
| Table of Contents |
Our intended consumer pricing is a free tier and two paid subscription tiers:
| Tier | Price | Intended inclusions |
| Free | $0 | 20 AI interactions per day, shared across AI coaching, photo meal analysis and meal suggestions; access to one structured program; wearable connection and progress tracking. |
| Plus | $9.99 / month | All free features, plus access to all five structured programs, one active at a time. |
| Pro | $24.99 / month | All Plus features, plus an extended conversation context window for the AI assistant; a higher response-length limit; expanded personalization in photo-based meal analysis, drawing on a larger history of the user’s own corrections; export of logged wellness data as a file; and enrollment in up to two structured programs concurrently. |
For organizations, our administrative dashboard contemplates per-participant pricing. We have not sold any subscriptions, have no validated pricing from real-world use, and our assumptions regarding adoption, conversion, and retention are unproven. We present no revenue projections.
Competition
The general health-and-wellness application market is large and intensely competitive and includes numerous well-funded companies offering applications with overlapping features. The individual capabilities of our application — assistive coaching, meal and habit tracking, photo-based food logging, and barcode lookup — are individually available in many competing products, and comparable functionality is also available through general-purpose consumer software and widely available AI assistants.
| Capability | Also offered by | Our position |
| Conversational wellness guidance | General-purpose AI assistants; other wellness apps | We use the same kind of third-party AI; no proprietary advantage |
| Meal / calorie tracking | Numerous established nutrition apps | Standard capability; established competitors have far more users and data |
| Photo-based food logging | Several nutrition apps | Standard capability |
| Wearable synchronization | Most major fitness platforms | Native device capture not yet implemented |
| Structured programs | Many fitness and wellness apps | Standard capability |
We have no proprietary artificial-intelligence technology, no patents, and no unique technical capability. As a development-stage company with no users, no revenue, no brand recognition, and limited capital, we are at a significant competitive disadvantage relative to established competitors, many of which have substantially greater financial, technical, marketing, and personnel resources than we do. See “Risk Factors.”
RESEARCH AND DEVELOPMENT; INTELLECTUAL PROPERTY
We have no intellectual property except our trade names and web domain. We do not own any patents and trademarks at this time, but we may pursue patents and or trademarks if we develop products via our product line group. We have not registered or trademarked “Elements Ventures Group Inc.” or any other trade names. There have not been any expenses incurred for any research or development other than the efforts of conducting research and analysis by our sole officer and director.
GOVERNMENTAL REGULATION
Depending on the nature of the data, our relationships with users, employers and health plans and how the information is collected, used and disclosed, we may be subject to various U.S. federal and state privacy and data protection laws and Canadian privacy laws. These may include HIPAA if we act as a business associate of a covered entity or health plan, the FTC’s Health Breach Notification Rule, state consumer health and privacy laws and PIPEDA and applicable provincial privacy laws in Canada. HIPAA generally applies to covered entities and their business associates, while the FTC Health Breach Notification Rule expressly reaches certain health applications and similar technologies that are not covered by HIPAA. Canadian privacy requirements may also apply to personal information collected, used or disclosed in commercial activities.
| 32 |
| Table of Contents |
Our failure to comply with any of these requirements or interpretations could have a material adverse effect on our operations.
Facilities
Our sole officer and director provides us with office space at no cost to us. Our current address is 9980 Dufferin Street #20026, Vaughan, Ontario L6A 4M4. Our telephone number is (647) 405-1054. This location serves as our primary office for planning and implementing our business plan.
Employees And Employment Agreements
We have no employees as of the date of this prospectus other than our sole officer and director, Dmitry Kinslikh who currently devotes approximately 40 hours per week to company matters. After receiving funding, Mr. Kinslikh plans to devote, as much time to the operation of the Company as he determines is necessary for him to manage the affairs of the Company. As our business and operations increase, we will assess the need for full-time management and administrative support personnel.
Legal Proceedings
There are no pending legal proceedings to which the Company is a party or in which any director, officer or affiliate of the Company, any owner of record or beneficially of more than 5% of any class of voting securities of the Company, or security holder is a party adverse to the Company or has a material interest adverse to the Company.
Market for Common Equity and Related Stockholder Matters
There is no established public trading market for our common stock. After the effective date of the registration statement of which this prospectus forms a part, we intend to seek a market maker to file an application with FINRA to have our common stock quoted on the OTC Pink Market. There is no assurance that any such application will be filed or approved or that a trading market will develop.
Holders. As of August 21, 2026, we had 40 holders of record of our common stock and 11,817,167 shares of common stock outstanding.
Common equity subject to outstanding options, warrants or convertible securities. We have no outstanding options or warrants. As of the date of this prospectus, we have outstanding convertible notes in the aggregate principal amount of $38,000. An aggregate of 2,5333,333 shares of our common stock are issuable upon conversion of those notes, consisting of 1,000,000 shares issuable under our May 29, 2026 note at a conversion price of $0.015 per share, 200,000 shares issuable under our November 14, 2025 note at a conversion price of $0.015 per share, and 1,333,333 shares issuable under our remaining convertible notes at conversion prices of $0.015. In addition, 5,000,000 shares of preferred stock have been designated as Series A Preferred Stock, each share of which would be convertible into 10,000 shares of common stock; no shares of Series A Preferred Stock are issued or outstanding. See "Description of Securities" and "Risk Factors."
Common equity that could be sold pursuant to Rule 144 or that is being registered. All 11,817,167 outstanding shares of our common stock are "restricted securities" as defined in Rule 144 under the Securities Act. Of these, 4,817,167 shares held by the selling stockholders are being registered for resale under the registration statement of which this prospectus forms a part, and the remaining 7,000,000 shares are held by our sole officer and director, an affiliate. Restricted securities may be sold under Rule 144 only if the conditions of that rule are satisfied, including, for affiliates, the volume, manner-of-sale and notice conditions, and, because we will initially report under Section 15(d) of the Exchange Act, the availability of current public information. In addition, if we were deemed to be a shell company, Rule 144 would not be available for resales of our securities pursuant to Rule 144(i) until at least one year after we cease to be a shell company and file the "Form 10 information" required by that rule, and only if we are then current in our reporting obligations.
| 33 |
| Table of Contents |
Dividends. We have not paid dividends on our common stock and do not anticipate paying dividends in the foreseeable future. Securities authorized for issuance under equity compensation plans. We do not have any equity compensation plans.
PLAN OF OPERATION
Our cash balance is $13,968 as of May 31, 2026. We do not believe that our cash balance is sufficient to fund our operations beyond one year’s time. However, our sole officer and director has verbally agreed to lend us funds in order to sustain our operations. During the period from inception until now, we have not generated any revenue.
Our independent registered public accountant has issued a going concern opinion. This means that there is a doubt that we can continue as an on-going business for the next twelve months unless we obtain additional capital to pay our bills. There is no assurance we will ever reach that stage. To meet our need for cash we are attempting to raise money from this offering. We believe that we will be able to raise enough money through this offering to expand operations, but we cannot guarantee that once we expand operations we will stay in business after doing so.
If we need additional cash and cannot raise it our director Dmitry Kinslikh verbally agreed to provide additional cash for the Company. We will not use the net proceeds from the offering to pay compensation to Mr. Kinslikh or to repay the loan from Mr. Kinslikh.
In the next twelve months, following completion of our public offering, we plan to engage in the following activities to expand our business operations, using funds as follows:
|
|
| 25% of Offering Sold |
|
| 50% of Offering Sold |
|
| 75% of Offering Sold |
|
| 100% of Offering Sold |
| ||||
| Gross Proceeds from this Offering (1) |
| $ | 525,000 |
|
| $ | 1,050,000 |
|
| $ | 1,575,000 |
|
| $ | 2,100,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares Sold |
|
| 1,500,000 |
|
|
| 3,000,000 |
|
|
| 4,500,000 |
|
|
| 6,000,000 |
|
| Gross Proceeds |
| $ | 525,000 |
|
| $ | 1,050,000 |
|
| $ | 1,575,000 |
|
| $ | 2,100,000 |
|
| Total Before Expenses |
| $ | 525,000 |
|
| $ | 1,050,000 |
|
| $ | 1,575,000 |
|
| $ | 2,100,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Administrative Offering Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal & Accounting |
| $ | 20,000 |
|
| $ | 20,000 |
|
| $ | 20,000 |
|
| $ | 20,000 |
|
| Publishing/EDGAR |
| $ | 2,000 |
|
| $ | 2,000 |
|
| $ | 2,000 |
|
| $ | 2,000 |
|
| Transfer Agent |
| $ | 2,000 |
|
| $ | 2,000 |
|
| $ | 2,000 |
|
| $ | 2,000 |
|
| SEC Filing Fee |
| $ | 406.55 |
|
| $ | 406.55 |
|
| $ | 406.55 |
|
| $ | 406.55 |
|
| Miscellaneous |
| $ | 593.45 |
|
| $ | 593.45 |
|
| $ | 593.45 |
|
| $ | 593.45 |
|
| Total Administrative Operating Expenses |
| $ | 25,000 |
|
| $ | 25,000 |
|
| $ | 25,000 |
|
| $ | 25,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net Offering Proceeds |
| $ | 500,000 |
|
| $ | 1,025,000 |
|
| $ | 1,550,000 |
|
| $ | 2,075,000 |
|
| Use of Net Proceeds |
|
|
|
|
|
|
|
|
|
|
|
| ||||
| Product deployment, launch & development |
| $ | 143,000 |
|
| $ | 293,150 |
|
| $ | 443,300 |
|
| $ | 593,450 |
|
| Personnel |
| $ | 107,000 |
|
| $ | 219,350 |
|
| $ | 331,700 |
|
| $ | 444,050 |
|
| Sales & business development |
| $ | 71,500 |
|
| $ | 146,575 |
|
| $ | 221,650 |
|
| $ | 296,725 |
|
| Marketing & user acquisition |
| $ | 59,500 |
|
| $ | 121,975 |
|
| $ | 184,450 |
|
| $ | 246,925 |
|
| Third-party services & infrastructure |
| $ | 35,500 |
|
| $ | 72,775 |
|
| $ | 110,050 |
|
| $ | 147,325 |
|
| Strategic cash reserves |
| $ | 59,500 |
|
| $ | 121,975 |
|
| $ | 184,450 |
|
| $ | 246,925 |
|
| General & administrative expense |
| $ | 24,000 |
|
| $ | 49,200 |
|
| $ | 74,400 |
|
| $ | 99,600 |
|
| Total |
| $ | 500,000 |
|
| $ | 1,025,000 |
|
| $ | 1,550,000 |
|
| $ | 2,075,000 |
|
| 34 |
| Table of Contents |
If the need for cash arises before we complete our public offering, we may be able to borrow funds from our director although there is no such formal agreement in writing. As of May 31, 2026, our director has loaned us $99,870 on no interest terms. We do not expect to purchase or sell plant or significant equipment. Further we do not expect significant changes in the number of employees. Upon completion of our public offering, our specific goal is to further develop and profitably sell our services. Our plan of operations is as follows:
Priority and Near-Term Deployment Plan
We have a specific, sequenced plan to deploy the proceeds, beginning immediately after closing, to launch FITLY and commence operations. Our intended near-term sequence is as follows:
Months 1–3 — Deployment and launch readiness. Provision and deploy production hosting infrastructure; complete configuration and testing of the application against live third-party services (including the third-party application-programming-interface, billing, and analytics services we use); finalize app-store assets; and submit the application to the Apple App Store and Google Play Store. We estimate the cost of this phase at approximately $150,000, drawn primarily from the product deployment and third-party services categories.
Months 3–6 — Launch and initial user acquisition. Following app-store approval, launch the application; begin initial, measured marketing and user-acquisition activity; and engage one to two technical personnel or contractors to support the deployed application. We estimate the cost of this phase at approximately $400,000.
Months 6–18 — Operation, iteration, and enterprise outreach. Operate and improve the application based on real usage; continue user-acquisition activity; and begin outreach to prospective employer and health-plan customers using the administrative dashboard. The balance of the proceeds is intended to fund this phase and our general operations for the remainder of the 18-to-24-month period.
The foregoing amounts and sequence are estimates and may change. Because this offering has no minimum, if we raise less than the full amount we will prioritize the deployment and launch activities described under Months 1–3 above, then the remaining categories in the order listed, scaling personnel, marketing, and business-development spending to the capital actually available. The following table illustrates our intended priority at different funding levels.
| Funding level | Gross proceeds (approx.) | Priorities funded |
| 25% | $525,000 | Deployment & launch; minimal personnel and infrastructure; limited marketing |
| 50% | $1,050,000 | Above, plus expanded personnel and initial user acquisition |
| 75% | $1,575,000 | Above, plus broader marketing and initial enterprise outreach |
| 100% | $2,100,000 | Full plan as described above |
SEC Filing Plan
We intend to become a reporting company in 2026 after our registration statement on Form S-1 is declared effective. This means that we will file documents with the United States Securities and Exchange Commission on a quarterly basis.
| 35 |
| Table of Contents |
Management's Discussion and Analysis of Financial Condition and Results of Operations
Limited operating history; and the need for additional capital.
There is no historical financial information about us upon which to base an evaluation of our performance. We are in start-up stage operations and have not generated any revenues. We cannot guarantee we will be successful in our business operations. Our business is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources and possible cost overruns due to price and cost increases in services and products.
During our last fiscal year, our monthly burn rate was approximately $3,434. However, this number is not an accurate reflection of our actual monthly cash requirement, as it will likely to be higher once we commence operations. We anticipate a monthly burn rate of approximately $10,000 per month after we commence operations.
Results of Operations for Year Ended August 31, 2025 compared to the Year Ended August 31, 2024
Revenues
We have had no operating revenues since our inception on January 31, 2022to August 31, 2025.
Expenses and Net Loss
We incurred operating expenses in the amount of $16,091 for the year ended August 31, 2025, compared to total operating expenses of $44,493 for the year ended August 31, 2024. The decrease in operating expenses in 2025 can be attributed to the fact that we had higher audit and consulting fees in 2024.
For the year ended August 31, 2025, our operating expenses were comprised of $5,950 in consulting charges, $508 in general and administrative expenses, $9,000 in related party consulting fees and $633 in depreciation expense. For the year ended August 31, 2024, operating expenses were comprised of $13,200 in audit fees, $9,000 in consulting charges, $6,269 in general and administrative expenses, $2,000 in related party consulting fees, $8,400 in professional fees and $624 in depreciation expense.
Consulting expense in the periods presented consisted principally of amounts paid to Total Site Maintenance Inc., an unaffiliated third-party consultant, engaged under a consulting services agreement dated November 10, 2023. In fiscal 2024 we paid $14,000 for market research (market sizing, competitive benchmarking, demographic and pricing analysis) and brand foundation work (naming validation, trademark screening, visual identity and audience research), which also included a preliminary technical assessment of alternatives for delivering the intended AI-based functionality. In fiscal 2025 we incurred $5,950 for assistance with the preparation of narrative disclosure for our prior registration statement. No consultant performed software development work. The remaining operating expenses consist of professional fees for audit, accounting and legal services, filing and transfer agent fees, and general administrative costs.
Net loss for the year ended August 31, 2025, was $16,645 as compared with $44,810 for the year ended August 31, 2024.
For the year ended August 31, 2025, the Company recorded a loss per share of $0.00 as compared to $0.00 for the year ended August 31, 2024.
Liquidity and Capital Resources
As of August 31, 2025 we had cash reserves of $10,838 and a working capital deficit of $82,503. For the year ended August 31, 2024 we had cash reserves of $1,252, and a working capital deficit of $74,085. The increase in deficit was due to an increase operating activities. We require approximately $80,000 to implement our business plan.
Our CEO has agreed to provide funding necessary to cover minimal operations. Basic funding specifically means the costs such as legal, accounting, EDGAR, SEC reporting and minimal administration costs. Our CEO has not agreed to offer any funding that may be required to commence further operations or hire employees. The anticipated amount of this loan will not be known at until the time a loan is determined to be needed. The amount will be based on the amount of funding needed to maintain minimal operation and the cost of becoming a public company from that point in time going forward. There are no specific repayment terms. The arrangement with Mr. Kinslikh is open-ended, and it will consist of loans that we will be required to repay. Mr. Kinslikh is not obligated to make any further advances. We have no agreement, commitment or understanding to secure any such funding from any other source.
| 36 |
| Table of Contents |
At this time, we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock or through a loan from our director to meet our obligations over the next twelve months. We have no plans regarding obtaining interim additional financing to sustain our business, and we do not have any arrangements or plans for arrangements in place for any future equity financing. If we are unable to raise the required financing, our operations could be materially adversely affected and we could be forced to cease operations.
Our auditors have issued a going concern opinion. This means that there is substantial doubt that we can continue as an ongoing business for the next twelve months.
Cash Used in Operating Activities
We received net cash in operating activities of $1,992 for the year ended August 31, 2025 compared to using $16,269 for the year ended August 31, 2024. The difference can be attributed to an increase in accounts payable which occurred during the year ended August 31, 2024.
Cash from Financing Activities
We have funded our business to date primarily from loans, notes payable and sale of common stock. We received net cash of $8,000 from the proceeds from sale of common stock during the year ended August 31, 2025 compared to $6,000 for the year ended August 31, 2024.
There are no assurances that we will be able to achieve further sales of our common stock or any other form of additional financing.
Cash Used in Investing Activities
During the year ended August 31, 2025, the Company used $393 of cash in investing activities compared to using $nil in investing activities for the year ended August 31, 2024.
Results of Operation for the Three Months Ended May 31, 2026 Compared to the Three Months Ended May 31, 2025
Revenues
We have had no operating revenues since our inception on January 31, 2022 to May 31, 2026.
Expenses and Net Loss
Operating expenses for the three months ended May 31, 2026 and May 31, 2025, consisted of general and administrative expenses of $350 and $68, respectively. During the three months ended May 31, 2026, we incurred $2,655 in audit fees compared to $nil for the same period in 2025. We incurred $177 in depreciation expense for the three months ended May 31, 2026, compared to $157 for the same period in 2025. The overall increase in expenses was due to an increase in audit fees.
Our net loss for the three months ended May 31, 2026 was $3,478 compared to $364 for the prior period.
Results of Operation for the Nine months Ended May 31, 2026 Compared to the Nine months Ended May 31, 2025
| 37 |
| Table of Contents |
Revenues
We have had no operating revenues since our inception on January 31, 2022 to May 31, 2026.
Expenses and Net Loss
Operating expenses from for the nine months ended May 31, 2026 and May 31, 2025, consisted of audit fees of $10,655 and $nil, respectively as well as general and administrative expenses of $1,865, and $433. During the nine months ended May 31, 2026, we incurred $nil in related party consulting fees compared to $3,000 for the same period in 2025. We incurred $525 in depreciation expense for the nine months ended May 31, 2026, compared to $466 for the same period in 2025. The overall increase in expenses was due to an increase in audit fees.
Liquidity and Capital Resources
As reflected in the accompanying financial statements, the Company has an accumulated deficit of $156,402 at May 31, 2026.
For the nine months ended May 31, 2026, we received $3,080 of cash in operating activities, compared to using $933 for the nine months ended May 31, 2025.
We used net cash of $nil in investing activities for the nine months ended May 31, 2026 and 2025.
Net cash received from financing activities for the nine months ended May 31, 2026 was $nil compared to $8,000 provided by financing activities in the prior period.
Changes In and Disagreements with Accountants
We have had no changes in or disagreements with our accountants.
Critical Accounting Policies
The preparation of our financial statements in accordance with United States generally accepted accounting principles requires that management make estimates and assumptions that impact the amounts reported in our Financial Statements and accompanying notes. Therefore, these estimates and assumptions affect reported amounts of assets, liabilities, revenue, expenses and associated disclosures of contingent liabilities. Management evaluates these estimates on an ongoing basis, utilizing historical experience, consultation with third parties and other methods considered reasonable in the particular circumstances. Nevertheless, actual results may differ significantly from our estimates. Any effects on our business, financial position or results of operations resulting from revisions to these estimates are recognized in the accounting period in which the facts that give rise to the revision become known. We consider our critical accounting policies and estimates to be those that require us to make more significant judgments and estimates when we prepare our financial statements and include the following:
Cash and Cash Equivalents
For purposes of the statement of cash flows, the Company considers all short-term debt securities purchased with maturity of three months or less to be cash equivalents.
Property and Equipment
Property and equipment are carried at cost. Expenditures for maintenance and repairs are charged against operations. Renewals and betterments that materially extend the life of the assets are capitalized. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in income for the period.
| 38 |
| Table of Contents |
Depreciation is computed for financial statement purposes on a straight-line basis over estimated useful lives of the related assets. The estimated useful lives of depreciable assets are:
|
| Estimated Useful Lives |
| Computers and Printers | 5 years |
For financial statements purposes, depreciation is computed under the straight-line method.
| 39 |
| Table of Contents |
Software Development Policy
In accordance with ASC 985-20-25, Costs of Software to Be Sold, Leased, or Marketed, software development costs are expensed as incurred until technological feasibility and marketability has been established, generally with release of a trial version for customer testing. Once the point of technological feasibility and marketability is reached, direct production costs (including labor directly associated with the development projects), indirect costs (including allocated fringe benefits, payroll taxes, facilities costs, and management supervision), and other direct costs (including costs of outside consultants, purchased software to be included in the software product being developed, travel expenses, material and supplies, and other direct costs) are capitalized until the product is available for general release to customers. We will amortize capitalized costs on a product-by-product basis. Amortization for each period is the greater of the amount computed using (i) the straight-line basis over the estimated product life (generally from 12 to 18 months, but up to 60 months), or (ii) the ratio of current revenues to total projected product revenues.
Capitalized software development costs are stated at the lower of amortized costs or net realizable value. Recoverability of these capitalized costs is determined at each balance sheet date by comparing the forecasted future revenues from the related products, based on management’s best estimates using appropriate assumptions and projections at the time, to the carrying amount of the capitalized software development costs. If the carrying value is determined not to be recoverable from future revenues, an impairment loss is recognized equal to the amount by which the carrying amount exceeds the future revenues.
ASC 730, Research and Development, established accounting and reporting standards for research and development. In accordance with ASC 730-10, costs we incur to enhance our existing products after general release to the public (bug fixes) are expensed in the period they are incurred and will be included in research and development costs. Research and development costs incurred prior to determination of technological feasibility and marketability and after general release to the public and charged to expense
The Company is intended to develop the software in-house and as of the reporting period, company didn’t incur any cost related the software development experience.
Translation Adjustment
For the year ended August 31, 2025, the accounts of the Company were maintained, and one bank statement was expressed, in CAD. Such statements were translated into USD in accordance with the Foreign Currency Matters Topic of the Codification (ASC 830), with USD as the functional currency. According to the Codification, all assets and liabilities were translated at the current exchange rate at respective balance sheets dates, stockholders’ equity are translated at the historical rates and income statement items are translated at the average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with the Comprehensive Income Topic of the Codification (ASC 220), as a component of members’ capital. Transaction gains and losses are reflected in the income statement.
Comprehensive Income/(Loss)
The Company uses SFAS 130 “Reporting Comprehensive Income” (ASC Topic 220). Comprehensive income is comprised of net income and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive loss for the year ended May 31, 2026, is included in the statement of operations as a foreign currency translation adjustment.
Income Taxes
Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.
| 40 |
| Table of Contents |
Basic Income (Loss) Per Share
The Company computes income (loss) per share in accordance with FASB ASC 260 “Earnings per Share”. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is antidilutive. There were no potentially dilutive debt or equity instruments issued or outstanding as of May 31, 2026.
Revenue recognition
We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers. The standard’s stated core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 includes provisions within a five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation.
DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS
The following table provides selected information about our management.
| Name |
| Age |
|
| Positions | ||
| Dmitry Kinslikh |
|
| 49 |
|
| President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director | |
Mr. Kinslikh has served as our President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer, and sole director since our incorporation on January 31, 2022, and conducts all of our management functions on a part-time basis. Our principal executive office is his address.
Mr. Kinslikh has worked in the health, rehabilitation, and wellness services sector since 2005. From 2010 to 2014, he operated a chain of health and rehabilitation clinics in the greater Toronto area, including Sunnybrook Rehabilitation Center, an established provider of physical-rehabilitation services for patients recovering from injuries and surgery. Over the same period and continuing today, he has founded and operated companies in the construction and excavation sector, providing services to commercial and residential clients: Primo Décor (2007–present), Excelsior (2010–2017), and Castleview (2017–present). He conceived FITLY and has directed its development since our incorporation.
There are no family relationships among our directors and executive officers. Our director holds office until the next annual meeting of shareholders or until his successor is duly elected and qualified, and our officers serve at the discretion of the board. Mr. Kinslikh does not serve as a director of any other company that has a class of securities registered under, or that is subject to the reporting requirements of, the Securities Exchange Act of 1934, or of any registered investment company. During the past ten years, Mr. Kinslikh has not been involved in any of the legal proceedings specified in Item 401(f) of Regulation S-K.
TERM OF OFFICE
All directors hold office until the next annual meeting of the stockholders of the Company and until their successors have been duly elected and qualified. The Company's Bylaws provide that the Board of Directors will consist of a minimum of one member. Officers are elected by and serve at the discretion of the Board of Directors. Our Bylaws provide to the fullest extent permitted by law that our directors or officers, former directors and officers, and persons who act at our request as a director or officer of a body corporate of which we are a shareholder or creditor shall be indemnified by us. We believe that the indemnification provisions in our By-laws are necessary to attract and retain qualified persons as directors and officers. Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers or persons controlling the Company pursuant to provisions of the State of Wyoming, the Company has been informed that, in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.
| 41 |
| Table of Contents |
DIRECTOR INDEPENDENCE
Our board of directors is currently composed of one member, and he does not qualify as an independent director in accordance with the published listing requirements of the NASDAQ Global Market (the Company has no plans to list on the NASDAQ Global Market).
AUDIT COMMITTEE AND CONFLICTS OF INTEREST
We do not have an audit or compensation committee comprised of independent directors.
Involvement In Certain Legal Proceedings
No director, person nominated to become a director, executive officer, promoter or control person of our company has, during the last ten years: (i) been convicted in or is currently subject to a pending a criminal proceeding (excluding traffic violations and other minor offenses); (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to any federal or state securities or banking or commodities laws including, without limitation, in any way limiting involvement in any business activity, or finding any violation with respect to such law, nor (iii) any bankruptcy petition been filed by or against the business of which such person was an executive officer or a general partner, whether at the time of the bankruptcy or for the two years prior thereto.
EXECUTIVE COMPENSATION
We have paid our sole officer and director Mr. Kinslikh $16,520 in cash since our inception to May 31, 2026.
EMPLOYMENT AGREEMENTS
We do not have an employment agreement with Mr. Kinslikh. We may enter into an employment agreement in the future.
DIRECTOR COMPENSATION
We have not compensated our directors for their service on our Board of Directors since our inception. There are no arrangements pursuant to which directors will be compensated in the future for any services provided as a director.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table lists, as of the date of this prospectus, the number of shares of common stock of our Company that are beneficially owned by (i) each person or entity known to our Company to be the beneficial owner of more than 5% of the outstanding common stock; (ii) each officer and director of our Company; and (iii) all officers and directors as a group.
| 42 |
| Table of Contents |
The percentages below are calculated based on 11,817,167 shares of our common stock issued and outstanding as of the date of this prospectus. .
|
Name and Address of Beneficial Owner |
Title of Class |
Number of Shares |
Percent of Common Stock
| |||||
|
Before Offering |
After Offering | |||||||
| Dmitry Kinslikh 9980 Dufferin St. #20026, Vaughan, Ontario L6A 4M4 | Common | 7,000,000 | 59.2% | 25% Sold | 50% Sold | 75% Sold | 100% Sold | |
| 52.6% | 47.2% | 42.9% | 39.3% | |||||
| All directors and executive officers as a group (1 person) | 59.2% | 52.6% | 47.2% | 42.9% | 39.3% | |||
| Roman Znamenski 77 Arjay Cres. Toronto ON M2L1C6 | Common | 700,000 | 5.9% | 5.3% | 4.72% | 4.29% | 3.93% | |
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Mr. Kinslikh has loaned us $46,870 as of August 31, 2025 ($47,897 as of May 31, 2026, including $1,027 of expenses he paid on our behalf during the nine months then ended). The loan does not have any term, carries no interest and is not secured.
On July 24, 2023, we received an advance of $12,500 from Jasbir Gill, a stockholder, and on February 10, 2025 we received an advance of $2,500 from Flex Bricks Ltd., a company controlled by Gurjeet Kooner, a stockholder. Each advance is unsecured, non-interest bearing, has no stated maturity, is due on demand, carries no conversion rights and is not evidenced by a promissory note or other written agreement. Advances from stockholders totalled $15,000 at each of August 31, 2025 and May 31, 2026.
INTERESTS OF NAMED EXPERTS AND COUNSEL
The financial statements included in this prospectus and in the registration statement have been audited by Michael Gillespie & Associates, PLLC, and are included in reliance upon such report given upon the authority of said firm as experts in auditing and accounting.
The legality of the common stock will be passed upon by Jackson L. Morris, Esq., St. Petersburg, Florida. He does not own any our common stock and we have no agreement to compensate him in our shares.
WHERE YOU CAN FIND MORE INFORMATION
We have filed with the Commission a Registration Statement on Form S-1, under the Securities Act of 1933, as amended, with respect to the securities offered by this prospectus. This prospectus, which forms a part of the registration statement, does not contain all the information set forth in the registration statement, as permitted by the rules and regulations of the Commission. For further information with respect to us and the securities offered by this prospectus, reference is made to the registration statement. The registration statement and other information may be read and copied at the Commission's Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the Commission at 1-800-SEC-0330. The Commission maintains a web site at http://www.sec.gov that contains reports and other information regarding issuers that file electronically with the Commission.
Once our Registration Statement is effective, management intends to file a Form 8-A which registers our class of common stock under Section 12 of the Exchange Act and to file reports pursuant to Section 13(a)of the Securities Exchange Act of 1934, as amended.
| 43 |
| Table of Contents |
INDEX TO FINANCIAL STATEMENTS
Elements Ventures Group Inc.
TABLE OF CONTENTS
ELEMENTS VENTURES GROUP INC.
For the years ended August 31, 2025 and 2024
| F-1 |
| Table of Contents |
MICHAEL GILLESPIE & ASSOCIATES, PLLC
CERTIFIED PUBLIC ACCOUNTANTS
Vancouver, WA 98666
206.353.5736
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders & Board of Directors
Elements Ventures Group Inc.
Opinion on the Financial Statements
We have audited the accompanying balance sheets of Elements Ventures Group Inc. as of August 31, 2025 and 2024 and the related statements of operations, changes in stockholders’ deficit, cash flows, and the related notes (collectively referred to as “financial statements”) for the years then ended. In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of August 31, 2025 and 2024 and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.
Going Concern
The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note #1 to the financial statements, although the Company has limited operations it has yet to attain profitability. This raises substantial doubt about its ability to continue as a going concern. Management’s plan in regard to these matters is also described in Note #1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
Critical Audit Matters
Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.
/S/ MICHAEL GILLESPIE & ASSOCIATES, PLLC
We have served as the Company’s auditor since 2023.
PCAOB ID 6104
Vancouver, Washington
May 14, 2026
| F-2 |
| Table of Contents |
Elements Ventures Group Inc.
Financial Statements
For the Year Ended August 31, 2025
(expressed in US dollars)
BALANCE SHEETS
(expressed in US dollars)
|
|
| August 31, 2025 |
|
| August 31, 2024 |
| ||
|
|
|
|
|
|
|
| ||
| ASSETS |
|
|
|
|
|
| ||
| Current assets: |
|
|
|
|
|
| ||
| Cash and cash equivalents |
| $ | 10,838 |
|
| $ | 1,252 |
|
| Total current assets |
|
| 10,838 |
|
|
| 1,252 |
|
| Property and equipment |
|
|
|
|
|
|
|
|
| Property and equipment gross |
|
| 3,510 |
|
|
| 3,117 |
|
| Less: accumulated depreciation |
|
| (1,697 | ) |
|
| (1,064 | ) |
| Property and equipment net |
|
| 1,813 |
|
|
| 2,053 |
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
| $ | 12,651 |
|
| $ | 3,305 |
|
|
|
|
|
|
|
|
|
|
|
| LIABILITIES AND STOCKHOLDERS’ DEFICIT |
|
|
|
|
|
|
|
|
| Current liabilities: |
|
|
|
|
|
|
|
|
| Accounts payable |
|
| 10,600 |
|
|
| 10,600 |
|
| Accrued interest payable - related parties (Note 4) |
|
| 871 |
|
|
| 317 |
|
| Loans payable - related party, director (Note 4) |
|
| 46,870 |
|
|
| 40,920 |
|
| Advance from stockholder - related party (Note 4) |
|
| 15,000 |
|
|
| 12,500 |
|
| Convertible notes payable - related parties (Note 4) |
|
| 20,000 |
|
|
| 11,000 |
|
| Total current liabilities |
|
| 93,341 |
|
|
| 75,337 |
|
|
|
|
|
|
|
|
|
|
|
| Total liabilities |
| $ | 93,341 |
|
| $ | 75,337 |
|
|
|
|
|
|
|
|
|
|
|
| STOCKHOLDERS’ DEFICIT: |
|
|
|
|
|
|
|
|
| Preferred stock: $0.0001 par value, 20,000,000 shares authorized, of which 5,000,000 designated Series A; none issued and outstanding |
| $ | - |
|
| $ | - |
|
| Common stock: $0.0001 par value, 500,000,000 shares authorized; 11,817,167 and 11,790,500 shares issued and outstanding, respectively |
|
| 1,182 |
|
|
| 1,179 |
|
| Additional paid in capital |
|
| 60,128 |
|
|
| 52,131 |
|
| Accumulated deficit |
|
| (141,494 | ) |
|
| (124,849 | ) |
| Accumulated other comprehensive loss |
|
| (506 | ) |
|
| (493 | ) |
| Total stockholders’ deficit |
| $ | (80,690 | ) |
| $ | (72,032 | ) |
|
|
|
|
|
|
|
|
|
|
| Total liabilities and stockholders’ deficit |
| $ | 12,651 |
|
| $ | 3,305 |
|
The accompanying notes are an integral part of these financial statements.
| F-3 |
| Table of Contents |
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(expressed in US dollars)
|
|
| Year ended August 31, 2025 |
|
| Year ended August 31, 2024 |
| ||
|
|
|
|
|
|
|
| ||
| Revenue |
| $ | — |
|
| $ | — |
|
|
|
|
|
|
|
|
|
|
|
| Operating expenses |
|
|
|
|
|
|
|
|
| Audit fees |
|
| — |
|
|
| 13,200 |
|
| Consulting charges (Note 2) |
|
| 5,950 |
|
|
| 14,000 |
|
| Professional fees |
|
| — |
|
|
| 8,400 |
|
| Related party consulting fees (Note 4) |
|
| 9,000 |
|
|
| 2,000 |
|
| General and administrative |
|
| 508 |
|
|
| 6,269 |
|
| Depreciation |
|
| 633 |
|
|
| 624 |
|
| Total operating expenses |
|
| 16,091 |
|
|
| 44,493 |
|
|
|
|
|
|
|
|
|
|
|
| Loss from operations |
|
| (16,091 | ) |
|
| (44,493 | ) |
|
|
|
|
|
|
|
|
|
|
| Other expense |
|
|
|
|
|
|
|
|
| Interest expense — related parties (Note 4) |
|
| (554 | ) |
|
| (317 | ) |
|
|
|
|
|
|
|
|
|
|
| Loss before income taxes |
|
| (16,645 | ) |
|
| (44,810 | ) |
| Provision for income taxes (Note 6) |
|
| — |
|
|
| — |
|
| Net loss |
| $ | (16,645 | ) |
| $ | (44,810 | ) |
|
|
|
|
|
|
|
|
|
|
| Other comprehensive loss |
|
|
|
|
|
|
|
|
| Foreign currency transaction gain (loss) |
|
| (3 | ) |
|
| 15 |
|
| Foreign currency translation adjustment |
|
| (10 | ) |
|
| (265 | ) |
| Total other comprehensive loss |
|
| (13 | ) |
|
| (250 | ) |
| Comprehensive loss |
| $ | (16,658 | ) |
| $ | (45,060 | ) |
|
|
|
|
|
|
|
|
|
|
| Net loss per common share — basic and diluted |
| $ | (0.00 | ) |
| $ | (0.00 | ) |
| Weighted average number of common shares outstanding — basic and diluted |
|
| 11,797,806 |
|
|
| 11,779,025 |
|
The accompanying notes are an integral part of these financial statements.
| F-4 |
| Table of Contents |
STATEMENTS OF STOCKHOLDERS’ DEFICIT
For the years ended August 31, 2025 and 2024
(expressed in US dollars)
|
|
| Common stock — shares |
|
| Common stock — amount |
|
| Additional paid-in capital |
|
| Accumulated deficit |
|
| Accumulated other comprehensive loss |
|
| Total stockholders’ deficit |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
| Balance, August 31, 2023 |
|
| 11,770,500 |
|
| $ | 1,177 |
|
| $ | 46,133 |
|
| $ | (80,039 | ) |
| $ | (243 | ) |
| $ | (32,972 | ) |
| Shares issued for cash (Note 5) |
|
| 20,000 |
|
|
| 2 |
|
|
| 5,998 |
|
|
| — |
|
|
| — |
|
|
| 6,000 |
|
| Foreign currency translation adjustment |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| (250 | ) |
|
| (250 | ) |
| Net loss |
|
| — |
|
|
| — |
|
|
| — |
|
|
| (44,810 | ) |
|
| — |
|
|
| (44,810 | ) |
| Balance, August 31, 2024 |
|
| 11,790,500 |
|
|
| 1,179 |
|
|
| 52,131 |
|
|
| (124,849 | ) |
|
| (493 | ) |
|
| (72,032 | ) |
| Shares issued for cash (Note 5) |
|
| 26,667 |
|
|
| 3 |
|
|
| 7,997 |
|
|
| — |
|
|
| — |
|
|
| 8,000 |
|
| Foreign currency translation adjustment |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| (13 | ) |
|
| (13 | ) |
| Net loss |
|
| — |
|
|
| — |
|
|
| — |
|
|
| (16,645 | ) |
|
| — |
|
|
| (16,645 | ) |
| Balance, August 31, 2025 |
|
| 11,817,167 |
|
| $ | 1,182 |
|
| $ | 60,128 |
|
| $ | (141,494 | ) |
| $ | (506 | ) |
| $ | (80,690 | ) |
The accompanying notes are an integral part of these financial statements.
| F-5 |
| Table of Contents |
STATEMENTS OF CASH FLOWS
(expressed in US dollars)
|
|
| Year ended August 31, 2025 |
|
| Year ended August 31, 2024 |
| ||
|
|
|
|
|
|
|
| ||
| Cash flows from operating activities |
|
|
|
|
|
| ||
| Net loss |
| $ | (16,645 | ) |
| $ | (44,810 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
| Depreciation |
|
| 633 |
|
|
| 624 |
|
| Expenses paid by related party on behalf of the Company (non-cash; Note 4) |
|
| 5,950 |
|
|
| — |
|
| Changes in operating liabilities: |
|
|
|
|
|
|
|
|
| Accounts payable |
|
| — |
|
|
| 10,600 |
|
| Accrued interest payable — related parties |
|
| 554 |
|
|
| 317 |
|
| Net cash used in operating activities |
|
| (9,508 | ) |
|
| (33,269 | ) |
|
|
|
|
|
|
|
|
|
|
| Cash flows from investing activities |
|
|
|
|
|
|
|
|
| Purchase of property and equipment |
|
| (393 | ) |
|
| — |
|
| Net cash used in investing activities |
|
| (393 | ) |
|
| — |
|
|
|
|
|
|
|
|
|
|
|
| Cash flows from financing activities |
|
|
|
|
|
|
|
|
| Proceeds from loans from director |
|
| — |
|
|
| 7,000 |
|
| Repayment of loans from director |
|
| — |
|
|
| (1,000 | ) |
| Proceeds from advance from stockholder - related parties |
|
| 2,500 |
|
|
| — |
|
| Proceeds from convertible notes payable — related parties |
|
| 9,000 |
|
|
| 11,000 |
|
| Proceeds from sale of common stock |
|
| 8,000 |
|
|
| 6,000 |
|
| Net cash provided by financing activities |
|
| 19,500 |
|
|
| 23,000 |
|
|
|
|
|
|
|
|
|
|
|
| Effect of exchange rate changes on cash |
|
| (13 | ) |
|
| (250 | ) |
| Net increase (decrease) in cash |
|
| 9,586 |
|
|
| (10,519 | ) |
| Cash, beginning of year |
|
| 1,252 |
|
|
| 11,771 |
|
| Cash, end of year |
| $ | 10,838 |
|
| $ | 1,252 |
|
|
|
|
|
|
|
|
|
|
|
| Supplemental cash flow information |
|
|
|
|
|
|
|
|
| Cash paid for interest |
| $ | — |
|
| $ | — |
|
| Cash paid for income taxes |
|
| — |
|
|
| — |
|
| Non-cash financing activity: expenses paid by director on behalf of the Company, recorded as loans payable - related party |
|
| 5,950 |
|
|
| — |
|
The accompanying notes are an integral part of these financial statements.
| F-6 |
| Table of Contents |
NOTES TO THE FINANCIAL STATEMENTS
For the years ended August 31, 2025 and 2024
(expressed in US dollars)
Note 1 — Nature of Operations and Going Concern
Elements Ventures Group Inc. (the “Company”) was incorporated in the State of Wyoming on January 31, 2022. The Company is developing FITLY, an artificial-intelligence-enabled fitness and nutrition application intended to be delivered as a hosted, subscription-based service. The Company has not generated revenue and its operations to date have consisted of organizational activities, product feasibility analysis and development, and preparation of a registration statement on Form S-1.
Going concern
The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. In accordance with ASC 205-40, Presentation of Financial Statements — Going Concern, management has evaluated whether conditions and events, considered in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued.
The following conditions and events raise substantial doubt: (i) the Company has generated no revenue since inception and has incurred recurring losses from operations, including a net loss of $16,645 for the year ended August 31, 2025, resulting in an accumulated deficit of $141,494 at August 31, 2025; (ii) at August 31, 2025 the Company had cash of $10,838, total current liabilities of $93,341 and a working capital deficit of $82,503; (iii) convertible notes payable to a related party in the aggregate principal amount of $11,000 matured on September 28, 2024 and November 23, 2024 and remained unpaid at August 31, 2025 (the maturity dates of all convertible notes were subsequently extended to August 31, 2027 — see Note 7), a further convertible note of $9,000 matures on February 23, 2026, and the Company’s $15,000 non-interest bearing stockholder advance and loans from its director of $46,870 are repayable on demand — and the Company does not have the resources to repay these obligations; (iv) the Company has used cash in operating activities in every period since inception ($9,508 for the year ended August 31, 2025 and $33,269 for the year ended August 31, 2024) and has funded those outflows entirely through loans from its director and related parties and sales of common stock; and (v) management estimates that a minimum of approximately $80,000 is required to implement its plan of operations for the next twelve months, which substantially exceeds the Company’s existing capital resources.
Management’s plans to address these conditions are: (i) to raise up to $2,100,000 of gross proceeds in a self-underwritten, best-efforts public offering of up to 6,000,000 shares of common stock at $0.35 per share pursuant to a registration statement on Form S-1 filed on July 17, 2026; however, the offering has no minimum, the Company has received no commitments to purchase shares, and completion is outside the Company’s control; (ii) to rely on the verbal agreement of the Company’s sole officer and director to loan the Company funds sufficient to maintain minimal operations, including the costs of SEC reporting; however, this agreement is not legally binding and he is under no obligation to advance funds; and (iii) to seek additional loans from related parties or third parties, as it has in prior periods, although it has no agreements, commitments or understandings for any such financing.
Because the offering is a best-efforts offering with no minimum and no commitments, and because the director’s funding arrangement is not binding, management has concluded that its plans are not probable of being effectively implemented within one year after the date these financial statements are issued and, accordingly, do not alleviate the substantial doubt about the Company’s ability to continue as a going concern. Substantial doubt about the Company’s ability to continue as a going concern exists. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
| F-7 |
| Table of Contents |
Note 2 — Summary of Significant Accounting Policies
Basis of presentation
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”). The Company’s fiscal year ends on August 31. The financial statements are presented in US dollars, which is the Company’s functional and reporting currency.
Use of estimates
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Significant estimates include the useful lives of property and equipment, the valuation allowance on deferred tax assets, the assessment of embedded features in convertible notes and the going-concern evaluation. Actual results could differ from those estimates.
Cash and cash equivalents
The Company considers all highly liquid instruments with original maturities of three months or less to be cash equivalents. The Company had no cash equivalents at August 31, 2025 or 2024. Cash is held at one Canadian chartered bank in US-dollar and Canadian-dollar accounts.
Property and equipment
Property and equipment, consisting of computers and printers, are stated at cost less accumulated depreciation and are depreciated on a straight-line basis over estimated useful lives of five years. Expenditures for maintenance and repairs are expensed as incurred. When assets are retired or disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is recognized in operations.
Software development costs
The Company is developing the FITLY application, which is intended to be provided to users as a hosted, subscription-based service; users will access the application through a client that connects to the Company’s hosted software and will not take possession of the underlying software. Accordingly, the Company accounts for the costs of developing the application under ASC 350-40, Internal-Use Software. Costs incurred during the preliminary project stage — including conceptual formulation, evaluation of alternatives and project feasibility analysis — are expensed as incurred. Costs incurred during the application development stage, such as external direct costs of materials and services and payroll costs of employees directly associated with the project, are capitalized once the preliminary project stage is complete, management has authorized and committed to funding the project and it is probable the project will be completed and the software used as intended. Costs incurred in the post-implementation and operation stage, including training and maintenance, are expensed as incurred. Capitalized costs, if any, will be amortized on a straight-line basis over the estimated useful life of the software once it is ready for its intended use and will be evaluated for impairment under ASC 350-40-35 whenever events or changes in circumstances indicate the carrying amount may not be recoverable.
| F-8 |
| Table of Contents |
During the years ended August 31, 2025 and 2024, the Company incurred $5,950 and $14,000, respectively, of project feasibility analysis costs charged by a third-party consultant, Total Site Maintenance, in connection with the FITLY application. These costs were incurred during the preliminary project stage and were expensed as incurred within consulting charges. The remaining development of the application has been performed by the Company’s sole officer and director, whose services are described in Note 4; no development costs were capitalized and no intangible asset is recorded at August 31, 2025 or 2024. To the extent that the Company’s activities constitute research and development, related costs are expensed as incurred in accordance with ASC 730.
Convertible notes payable
The Company accounts for convertible notes payable in accordance with ASC 470-20, Debt with Conversion and Other Options, as amended by Accounting Standards Update (“ASU”) 2020-06, which the Company adopted as of September 1, 2021, the beginning of its first fiscal year (see “Recent accounting pronouncements”). Under this guidance, a convertible note is accounted for as a single liability measured at amortized cost unless (i) the conversion feature is required to be bifurcated and accounted for separately as a derivative under ASC 815, or (ii) the note was issued at a substantial premium. The Company evaluates each conversion feature at issuance and at each reporting date to determine whether it is indexed to the Company’s own stock and would be classified in stockholders’ equity under ASC 815-40 and therefore qualifies for the scope exception from derivative accounting in ASC 815-10-15-74(a).
Each of the Company’s convertible notes is convertible, at the holder’s option prior to maturity, into a fixed number of shares of common stock at a fixed conversion price of $0.015 per share, is settled only in shares, and contains no anti-dilution, price-reset, variable-conversion or cash-settlement provisions; accrued interest is payable in cash and is not convertible. The Company has concluded that the conversion features are indexed to its own stock and meet the conditions for equity classification and, in addition, that they do not meet the net-settlement characteristic of a derivative because the Company’s shares are not readily convertible to cash. Accordingly, no embedded derivative has been bifurcated, no beneficial conversion feature is recognized, and each note is carried at the principal amount advanced plus accrued interest, with interest expense recognized at the stated rate using the effective interest method. None of the notes was issued at a premium. Upon a conversion in accordance with the original terms, the carrying amount of the note is credited to common stock and additional paid-in capital with no gain or loss recognized.
Share-based compensation
The Company accounts for share-based payments in accordance with ASC 718, measuring equity-classified awards at the grant-date fair value of the equity instruments issued. In fiscal 2022, the Company recognized $400 of share-based compensation for services rendered by its founder in partial consideration for the 7,000,000 founder shares described in Note 5, measured by reference to the $0.0001 per share cash price paid by unrelated investors in contemporaneous transactions. No share-based payments were made during the years ended August 31, 2025 or 2024.
| F-9 |
| Table of Contents |
Fair value of financial instruments
The Company’s financial instruments consist of cash, accounts payable, accrued interest payable, loans and advances payable to related parties and convertible notes payable to related parties. The carrying amounts of these instruments approximate their fair values because of their short-term nature or, for the related-party loans and notes, because they are due on demand or within one year. ASC 820 establishes a three-level fair value hierarchy; the Company has no assets or liabilities measured at fair value on a recurring basis.
Related parties
The Company follows ASC 850, Related Party Disclosures, and discloses the nature of relationships, descriptions of transactions and amounts due to related parties in Note 4. Expenses paid by a related party on the Company’s behalf are recognized as expenses of the Company with a corresponding increase in amounts due to the related party.
Foreign currency
The Company’s functional and reporting currency is the US dollar. The Company maintains a Canadian-dollar bank account and incurs certain expenses in Canadian dollars. In accordance with ASC 830, Foreign Currency Matters, monetary assets and liabilities denominated in Canadian dollars are remeasured at the exchange rate in effect at the balance sheet date, and expenses are translated at average rates for the period. Remeasurement differences are recognized in operations; translation differences arising from the Canadian-dollar account are reported in other comprehensive loss. For the years ended August 31, 2025 and 2024, transaction gains and losses were $(3) and $15, respectively, and are presented with the translation adjustment in other comprehensive loss because they are not material.
Comprehensive loss
Comprehensive loss, presented in accordance with ASC 220, comprises net loss and other comprehensive loss, which for the Company consists of foreign currency translation adjustments. Accumulated other comprehensive loss is presented as a separate component of stockholders’ deficit.
Income taxes
Income taxes are accounted for under the asset and liability method of ASC 740. Deferred tax assets and liabilities are recognized for the future tax consequences of differences between the financial statement carrying amounts and tax bases of assets and liabilities and for net operating loss carryforwards, measured using enacted tax rates expected to apply when the differences reverse. A valuation allowance is recorded when it is more likely than not that some or all of a deferred tax asset will not be realized. The Company recognizes the effect of uncertain tax positions only if it is more likely than not that the position will be sustained on examination.
Loss per share
Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share gives effect to potentially dilutive common shares using the if-converted method for convertible notes, unless their effect is anti-dilutive. Because the Company incurred net losses in both periods, all potentially dilutive shares were anti-dilutive and diluted loss per share equals basic loss per share. Potentially dilutive common shares excluded from the computation consisted of 1,333,333 and 733,333 shares issuable upon conversion of convertible notes payable at August 31, 2025 and 2024, respectively (see Note 4).
| F-10 |
| Table of Contents |
Revenue recognition
The Company will recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers, when it satisfies performance obligations by transferring promised services to customers, in an amount that reflects the consideration to which it expects to be entitled. The Company has not generated revenue since inception.
Recent accounting pronouncements
In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40), which removed the separation models for beneficial conversion features and cash conversion features and requires convertible instruments to be accounted for as a single liability unless a derivative must be bifurcated or the instrument is issued at a substantial premium. The Company adopted ASU 2020-06 as of September 1, 2021, prior to the issuance of any convertible instrument; accordingly, there was no transition adjustment. The Company has reviewed other recently issued accounting pronouncements and does not believe any will have a material effect on its financial statements.
Note 3 — Property and Equipment
Property and equipment consists of computers and printers, depreciated on a straight-line basis over five years:
|
|
| August 31, 2025 |
|
| August 31, 2024 |
| ||
| Computers |
| $ | 2,589 |
|
| $ | 2,589 |
|
| Printers |
|
| 921 |
|
|
| 528 |
|
| Property and equipment, gross |
|
| 3,510 |
|
|
| 3,117 |
|
| Less: accumulated depreciation |
|
| (1,697 | ) |
|
| (1,064 | ) |
| Property and equipment, net |
| $ | 1,813 |
|
| $ | 2,053 |
|
Depreciation expense for the years ended August 31, 2025 and 2024 was $633 and $624, respectively.
Note 4 — Related Party Transactions and Notes Payable
Loans from director
Dmitry Kinslikh, the Company’s sole officer, director and principal stockholder, has advanced funds to the Company for working capital as follows: $15,500 during the year ended August 31, 2022; $20,000 during the year ended August 31, 2023, of which $580 was repaid; $7,000 during the year ended August 31, 2024, of which $1,000 was repaid; and $5,950 during the year ended August 31, 2025, consisting of $5,950 that Mr. Kinslikh paid directly to a third-party consultant on the Company’s behalf on August 25, 2025 (see “Software feasibility costs” below). At August 31, 2025 and 2024, the Company owed Mr. Kinslikh $46,870 and $40,920, respectively. The loans are unsecured, non-interest bearing, due on demand and not evidenced by written instruments. Mr. Kinslikh has verbally agreed to loan the Company funds sufficient to maintain minimal operations; this agreement is not legally binding.
| F-11 |
| Table of Contents |
Related party consulting fees and services
During the years ended August 31, 2025 and 2024, the Company paid Mr. Kinslikh consulting fees of $9,000 and $2,000, respectively, for management and administrative services, which are presented as related party consulting fees in the statements of operations. Mr. Kinslikh receives no salary. He has personally performed the design and development of the Company’s FITLY application (see Note 2). The Company evaluated the fair value of these services and concluded that the consulting fees paid, together with the $400 of share-based compensation recognized in fiscal 2022 (Note 5), reasonably reflect the cost of the services provided, and that the incremental fair value of any uncompensated services is not material to the financial statements.
Software feasibility costs paid by director
On August 17, 2025, the Company was invoiced $5,950 by Total Site Maintenance, a third-party consultant, for project feasibility analysis in connection with the FITLY application. Mr. Kinslikh paid the invoice on the Company’s behalf on August 25, 2025. The Company recognized the $5,950 as consulting expense with a corresponding increase in the amount due to Mr. Kinslikh; the transaction is a non-cash financing activity for purposes of the statement of cash flows.
Convertible notes payable — related parties
The Company has issued the following convertible promissory notes:
| Holder / date of note |
| Face amount |
|
| Principal advanced |
|
| Interest rate |
|
| Maturity date |
| Fixed conversion shares |
|
| Status at August 31, 2025 | |||||
| Capitale Matador Ltee — November 24, 2023 |
| $ | 5,000 |
|
| $ | 5,000 |
|
|
| 5 | % |
| November 23, 2024 |
|
| 333,333 |
|
| Matured; unpaid | |
| Capitale Matador Ltee — April 1, 2024 |
|
| 6,000 |
|
|
| 6,000 |
|
|
| 5 | % |
| September 28, 2024 |
|
| 400,000 |
|
| Matured; unpaid | |
| El Toro Capital Build Ltd — August 27, 2025 |
|
| 9,000 |
|
|
| 9,000 |
|
|
| 5 | % |
| February 23, 2026 |
|
| 600,000 |
|
| Current | |
| Total |
| $ | 20,000 |
|
| $ | 20,000 |
|
|
|
|
|
|
|
|
| 1,333,333 |
|
|
| |
Each note bears interest at 5% per annum, computed on a 365-day basis on the principal advanced, with principal and accrued interest due at maturity. At the holder’s option at any time prior to the maturity date, the entire principal amount of each note is convertible into the fixed number of shares of common stock shown above, representing a conversion price of $0.015 per share; accrued interest is payable in cash upon conversion and is not convertible. The Company may not prepay any note without the holder’s written consent. Each note is unsecured and contains no financial covenants. Failure to pay principal or interest when due, failure to deliver conversion shares within five business days of a conversion notice, and bankruptcy are events of default upon which the holder may declare all unpaid principal and interest immediately due and payable. The holders may assign the notes. The notes are governed by the laws of the Province of Ontario.
The executed instrument for the note dated August 27, 2025 erroneously states a principal amount of $12,000 convertible into 800,000 shares; $9,000 was advanced on that date and the further $3,000 was advanced on November 14, 2025 under a separate note described in Note 7. The liability recorded, and the principal and conversion shares presented above, reflect the $9,000 advanced at $0.015 per share; the instrument was corrected by an amendment dated as of August 31, 2026 (see Note 7).
| F-12 |
| Table of Contents |
The two Capitale Matador Ltee notes matured on September 28, 2024 and November 23, 2024 and had not been repaid at August 31, 2025 or at the date these financial statements were issued; the holder has not demanded payment or exercised its acceleration remedy, and interest continues to accrue at the contractual rate. On August 31, 2026, the notes were amended to extend their maturity dates to August 31, 2027, to waive the prior payment defaults and to confirm that the conversion rights remain in full force and effect (see Note 7). The Company has classified all convertible notes as current liabilities.
Interest expense on the convertible notes was $554 and $317 for the years ended August 31, 2025 and 2024, respectively. Accrued interest payable was $871 and $317 at August 31, 2025 and 2024, respectively, consisting at August 31, 2025 of $441 on the $5,000 note, $425 on the $6,000 note and $5 on the $9,000 note.
Capitale Matador Ltee is a related party; it is controlled by Elena Znamenskaya, who has voting and dispositive power over its shares. Ms. Znamenskaya holds 300,000 shares of the Company’s common stock directly and beneficially owns the 20,000 shares held by Capitale Matador Ltee. Roman Znamenski, her son, holds 700,000 shares of the Company’s common stock (approximately 5.9%). El Toro Capital Build Ltd is a related party; it is controlled by Marlis Guerra, who has voting and dispositive power over its shares and holds no shares of the Company in her own name. Both entities also purchased common stock from the Company (see below and Note 5).
Advance from stockholder
On July 24, 2023, the Company received an advance of $12,500 from Jasbir Gill, a stockholder of the Company. The advance is unsecured, non-interest bearing, has no stated maturity, is repayable on demand, carries no conversion rights and is not evidenced by a promissory note or other written instrument. The balance outstanding was $12,500 at August 31, 2025 and 2024. Mr. Gill holds 500,000 shares of the Company’s common stock and is the father of Jaswinder Gill and Tejpal Gill, who are also stockholders of the Company.
On February 10, 2025, the Company received an advance of $2,500 from Flex Bricks Ltd, a company controlled by Gurjeet Kooner stockholder of the Company. The advance is unsecured, non-interest bearing, has no stated maturity, is due on demand, carries no conversion rights and is not evidenced by a promissory note or other written instrument. The balance outstanding was $2,500 at August 31, 2025.
Sales of common stock to related parties
During the year ended August 31, 2024, the Company sold 20,000 shares of common stock to Capitale Matador Ltee for $6,000 ($0.30 per share), and during the year ended August 31, 2025 it sold 26,667 shares to El Toro Capital Build Ltd for $8,000 ($0.30 per share). See Note 5.
Summary of amounts due to related parties
|
|
| August 31, 2025 |
|
| August 31, 2024 |
| ||
| Loans from director, non-interest bearing, due on demand |
| $ | 46,870 |
|
| $ | 40,920 |
|
| Advance from stockholder, non-interest bearing, repayable on demand |
|
| 15,000 |
|
|
| 12,500 |
|
| Convertible notes payable, 5% |
|
| 20,000 |
|
|
| 11,000 |
|
| Accrued interest payable on convertible notes |
|
| 871 |
|
|
| 317 |
|
| Total due to related parties (all current) |
| $ | 82,741 |
|
| $ | 64,737 |
|
| F-13 |
| Table of Contents |
Note 5 — Stockholders’ Deficit
Common stock
The Company is authorized to issue 500,000,000 shares of common stock, par value $0.0001 per share. Shares issued since inception are as follows:
During the year ended August 31, 2022, the Company issued 7,000,000 shares to Dmitry Kinslikh, its sole officer and director, subscribed on January 31, 2022 pursuant to the Company’s organizational consent and issued on February 17, 2022, for aggregate consideration of $700, consisting of $300 in cash (received February 24, 2022) and services rendered to the Company by Mr. Kinslikh valued at $400, which was recognized as share-based compensation in fiscal 2022; and 4,740,500 shares to 34 other investors between February 7 and June 30, 2022 at prices ranging from $0.0001 to $0.10 per share for aggregate cash consideration of $39,110, for total fiscal 2022 consideration of $39,810 ($39,410 in cash and $400 in services). The fair value of the founder shares was measured at $0.0001 per share, the price at which unrelated investors purchased shares for cash in contemporaneous transactions. During the year ended August 31, 2023, the Company issued 30,000 shares to three investors at $0.25 per share for cash proceeds of $7,500. During the year ended August 31, 2024, the Company issued 20,000 shares to Capitale Matador Ltee, a related party (Note 4), at $0.30 per share for cash proceeds of $6,000. During the year ended August 31, 2025, the Company issued 26,667 shares to El Toro Capital Build Ltd, a related party (Note 4), at $0.30 per share for cash proceeds of $8,000.
There were 11,817,167 and 11,790,500 shares of common stock issued and outstanding at August 31, 2025 and 2024, respectively. At August 31, 2025, 1,333,333 shares of common stock were reserved for issuance upon conversion of the convertible notes described in Note 4.
Preferred stock
The Company is authorized to issue 20,000,000 shares of preferred stock, par value $0.0001 per share, of which 5,000,000 shares have been designated as Series A Preferred Stock pursuant to Articles of Amendment filed with the Wyoming Secretary of State on August 12, 2022. No shares of preferred stock were issued or outstanding at August 31, 2025 or 2024.
Each share of Series A Preferred Stock, if issued, would entitle the holder to 10,000 votes on all matters submitted to stockholders, voting together with the common stock as a single class, and would be convertible into 10,000 shares of common stock. The Series A Preferred Stock has no fixed dividend rate, no redemption feature and no fixed liquidation preference; upon liquidation it would participate pro rata with the common stock as a single class. So long as any Series A Preferred Stock is outstanding, certain corporate actions would require the affirmative vote of at least 67% of the outstanding Series A Preferred Stock voting separately as a class. Conversion of all 5,000,000 designated shares would require 50,000,000,000 shares of common stock, which exceeds the Company’s authorized common stock; any issuance of Series A Preferred Stock would therefore require an increase in authorized common stock or a limitation on conversion.
| F-14 |
| Table of Contents |
Note 6 — Income Taxes
The Company has incurred net losses since inception and has no current income tax liability. The provision for income taxes differs from the amount that would result from applying the US federal statutory rate of 21% to the loss before income taxes as follows:
|
|
| Year ended August 31, 2025 |
|
| Year ended August 31, 2024 |
| ||
| Income tax benefit at statutory rate |
| $ | (3,495 | ) |
| $ | (9,410 | ) |
| Change in valuation allowance |
|
| 3,495 |
|
|
| 9,410 |
|
| Income tax expense |
| $ | — |
|
| $ | — |
|
The components of the Company’s net deferred tax asset are as follows:
|
|
| August 31, 2025 |
|
| August 31, 2024 |
| ||
| Deferred tax asset — net operating loss carryforwards |
| $ | 29,714 |
|
| $ | 26,218 |
|
| Valuation allowance |
|
| (29,471 | ) |
|
| (26,218 | ) |
| Net deferred tax asset |
| $ | — |
|
| $ | — |
|
At August 31, 2025, the Company had net operating loss carryforwards for US federal income tax purposes of approximately $141,494. Because all of the Company’s losses arose in tax years beginning after December 31, 2017, the carryforwards do not expire, but their utilization is limited to 80% of taxable income in any year. Utilization may also be limited under Section 382 of the Internal Revenue Code if the Company undergoes an ownership change. Because realization of the deferred tax asset is not more likely than not, a full valuation allowance has been recorded; the valuation allowance increased by $3,495 and $9,410 during the years ended August 31, 2025 and 2024, respectively.
The Company has no uncertain tax positions and no accrued interest or penalties related to income taxes at August 31, 2025 or 2024. The Company’s tax returns since inception remain open to examination.
| F-15 |
| Table of Contents |
Note 7 — Subsequent Events
The Company evaluated all events or transactions that occurred after August 31, 2025, through May 14, 2026. Other than as disclosed below, no other subsequent events were identified requiring recording or disclosure in the financial statements for the period ended August 31, 2025.
On November 14, 2025, the Company entered into a convertible promissory note with El Toro Capital Build Ltd. for $3,000 with a maturity date of May 13, 2026. The note bears interest at 5% per annum and is convertible into 200,000 shares of common stock at a conversion price of $0.015 per share.
| F-16 |
| Table of Contents |
Elements Ventures Group Inc.
Financial Statements
For the Nine Months Ended May 31, 2026
(expressed in US dollars)
(unaudited)
| F-17 |
| Table of Contents |
ELEMENTS VENTURES GROUP INC.
CONDENSED FINANCIAL STATEMENTS (UNAUDITED)
For the three and nine months ended May 31, 2026 and 2025
(expressed in US dollars)
| F-18 |
| Table of Contents |
CONDENSED BALANCE SHEETS
(expressed in US dollars)
|
|
| May 31, 2026 |
|
| August 31, 2025 |
| ||
|
|
| (Unaudited) |
|
|
|
| ||
| ASSETS |
|
|
|
| ||||
| Current assets |
|
|
|
|
|
| ||
| Cash |
| $ | 13,968 |
| $ | 10,838 | ||
| Total current assets |
| 13,968 |
| 10,838 | ||||
|
|
|
|
|
|
|
|
|
|
| Property and equipment, at cost |
| 3,510 |
| 3,510 | ||||
| Less: accumulated depreciation |
| (2,223 | ) |
| (1,697 | ) | ||
| Property and equipment, net |
| 1,287 |
| 1,813 | ||||
|
|
|
|
|
|
|
|
|
|
| Total assets |
| $ | 15,255 |
| $ | 12,651 | ||
|
|
|
|
|
|
|
|
|
|
| LIABILITIES AND STOCKHOLDERS’ DEFICIT |
|
|
|
|
| |||
| Current liabilities |
|
|
|
|
|
|
|
|
| Accounts payable |
| $ | 8,200 |
| $ | 10,600 | ||
| Accrued interest payable — related parties (Note 4) |
| 1,706 |
| 871 | ||||
| Loans payable — related party, director (Note 4) |
| 47,897 |
| 46,870 | ||||
| Advance from stockholder — related party (Note 4) |
| 15,000 |
| 15,000 | ||||
| Convertible notes payable — related parties (Note 4) |
| 38,000 |
| 20,000 | ||||
| Total current liabilities |
| 110,803 |
| 93,341 | ||||
| Total liabilities |
| 110,803 |
| 93,341 | ||||
|
|
|
|
|
|
|
|
|
|
| Commitments and contingencies (Notes 1 and 4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ deficit (Note 5) |
|
|
|
|
|
|
|
|
| Preferred stock, $0.0001 par value; 20,000,000 shares authorized, of which 5,000,000 are designated Series A; none issued and outstanding |
| — |
| — | ||||
| Common stock, $0.0001 par value; 500,000,000 shares authorized; 11,817,167 shares issued and outstanding at each date |
| 1,182 |
| 1,182 | ||||
| Additional paid-in capital |
| 60,128 |
| 60,128 | ||||
| Accumulated deficit |
| (156,402 | ) |
| (141,494 | ) | ||
| Accumulated other comprehensive loss |
| (456 | ) |
| (506 | ) | ||
| Total stockholders’ deficit |
| (95,548 | ) |
| (80,690 | ) | ||
|
|
|
|
|
|
|
|
|
|
| Total liabilities and stockholders’ deficit |
| $ | 15,255 |
| $ | 12,651 | ||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| F-19 |
| Table of Contents |
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)
(expressed in US dollars)
|
|
| Three months ended May 31, 2026 |
|
| Three months ended May 31, 2025 |
|
| Nine months ended May 31, 2026 |
|
| Nine months ended May 31, 2025 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
| Revenue |
| $ | — |
|
| $ | — |
|
| $ | — |
|
| $ | — |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Audit fees |
|
| 2,655 |
|
|
| — |
|
|
| 10,655 |
|
|
| — |
|
| Related party consulting fees (Note 4) |
|
| — |
|
|
| — |
|
|
| — |
|
|
| 3,000 |
|
| General and administrative (Note 4) |
|
| 1,114 |
|
|
| 68 |
|
|
| 2,892 |
|
|
| 433 |
|
| Depreciation |
|
| 177 |
|
|
| 157 |
|
|
| 525 |
|
|
| 466 |
|
| Total operating expenses |
|
| 3,946 |
|
|
| 225 |
|
|
| 14,072 |
|
|
| 3,899 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss from operations |
|
| (3,946 | ) |
|
| (225 | ) |
|
| (14,072 | ) |
|
| (3,899 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest expense — related parties (Note 4) |
|
| (296 | ) |
|
| (139 | ) |
|
| (836 | ) |
|
| (410 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss before income taxes |
|
| (4,242 | ) |
|
| (364 | ) |
|
| (14,908 | ) |
|
| (4,309 | ) |
| Provision for income taxes |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
| Net loss |
| $ | (4,242 | ) |
| $ | (364 | ) |
| $ | (14,908 | ) |
| $ | (4,309 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Foreign currency transaction gain (loss) |
|
| 57 |
|
|
| — |
|
|
| 56 |
|
|
| — |
|
| Foreign currency translation adjustment |
|
| (6 | ) |
|
| — |
|
|
| (6 | ) |
|
| — |
|
| Total other comprehensive income |
|
| 51 |
|
|
| — |
|
|
| 50 |
|
|
| — |
|
| Comprehensive loss |
| $ | (4,191 | ) |
| $ | (364 | ) |
| $ | (14,858 | ) |
| $ | (4,309 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss per common share — basic and diluted |
| $ | (0.00 | ) |
| $ | (0.00 | ) |
| $ | (0.00 | ) |
| $ | (0.00 | ) |
| Weighted average number of common shares outstanding — basic and diluted |
|
| 11,817,167 |
|
|
| 11,793,109 |
|
|
| 11,817,167 |
|
|
| 11,791,379 |
|
The accompanying notes are an integral part of these unaudited condensed financial statements.
| F-20 |
| Table of Contents |
CONDENSED STATEMENTS OF STOCKHOLDERS’ DEFICIT (UNAUDITED)
For the nine months ended May 31, 2026 and 2025
(expressed in US dollars)
|
|
| Common stock — shares |
|
| Common stock — amount |
|
| Additional paid-in capital |
|
| Accumulated deficit |
|
| Accumulated other comprehensive loss |
|
| Total stockholders’ deficit |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
| Balance, August 31, 2024 |
|
| 11,790,500 |
|
| $ | 1,179 |
|
| $ | 52,131 |
|
| $ | (124,849 | ) |
| $ | (493 | ) |
| $ | (72,032 | ) |
| Net loss for the period |
|
| — |
|
|
| — |
|
|
| — |
|
|
| (359 | ) |
|
| — |
|
|
| (359 | ) |
| Balance, November 30, 2024 |
|
| 11,790,500 |
|
|
| 1,179 |
|
|
| 52,131 |
|
|
| (125,208 | ) |
|
| (493 | ) |
|
| (72,391 | ) |
| Net loss for the period |
|
| — |
|
|
| — |
|
|
| — |
|
|
| (3,586 | ) |
|
| — |
|
|
| (3,586 | ) |
| Balance, February 28, 2025 |
|
| 11,790,500 |
|
|
| 1,179 |
|
|
| 52,131 |
|
|
| (128,794 | ) |
|
| (493 | ) |
|
| (75,977 | ) |
| Shares issued for cash (Note 5) |
|
| 26,667 |
|
|
| 3 |
|
|
| 7,997 |
|
|
| — |
|
|
| — |
|
|
| 8,000 |
|
| Net loss for the period |
|
| — |
|
|
| — |
|
|
| — |
|
|
| (364 | ) |
|
| — |
|
|
| (364 | ) |
| Balance, May 31, 2025 |
|
| 11,817,167 |
|
| $ | 1,182 |
|
| $ | 60,128 |
|
| $ | (129,158 | ) |
| $ | (493 | ) |
| $ | (68,341 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, August 31, 2025 |
|
| 11,817,167 |
|
| $ | 1,182 |
|
| $ | 60,128 |
|
| $ | (141,494 | ) |
| $ | (506 | ) |
| $ | (80,690 | ) |
| Net loss for the period |
|
| — |
|
|
| — |
|
|
| — |
|
|
| (567 | ) |
|
| — |
|
|
| (567 | ) |
| Balance, November 30, 2025 |
|
| 11,817,167 |
|
|
| 1,182 |
|
|
| 60,128 |
|
|
| (142,061 | ) |
|
| (506 | ) |
|
| (81,257 | ) |
| Net loss for the period |
|
| — |
|
|
| — |
|
|
| — |
|
|
| (10,099 | ) |
|
| — |
|
|
| (10,099 | ) |
| Balance, February 28, 2026 |
|
| 11,817,167 |
|
|
| 1,182 |
|
|
| 60,128 |
|
|
| (152,160 | ) |
|
| (506 | ) |
|
| (91,356 | ) |
| Foreign currency translation adjustment |
|
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
|
| 50 |
|
|
| 50 |
|
| Net loss for the period |
|
| — |
|
|
| — |
|
|
| — |
|
|
| (4,242 | ) |
|
| — |
|
|
| (4,242 | ) |
| Balance, May 31, 2026 |
|
| 11,817,167 |
|
| $ | 1,182 |
|
| $ | 60,128 |
|
| $ | (156,402 | ) |
| $ | (456 | ) |
| $ | (95,548 | ) |
The accompanying notes are an integral part of these unaudited condensed financial statements.
| F-21 |
| Table of Contents |
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
(expressed in US dollars)
|
|
| Nine months ended May 31, 2026 |
|
| Nine months ended May 31, 2025 |
| ||
|
|
|
|
|
|
|
| ||
| Cash flows from operating activities |
|
|
|
|
|
| ||
| Net loss |
| $ | (14,908 | ) |
| $ | (4,309 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
| Depreciation |
|
| 525 |
|
|
| 466 |
|
| Expenses paid by related party on behalf of the Company (Note 4) |
|
| 1,027 |
|
|
| — |
|
| Changes in operating liabilities: |
|
|
|
|
|
|
|
|
| Accounts payable |
|
| (2,400 | ) |
|
| — |
|
| Accrued interest payable — related parties |
|
| 836 |
|
|
| 410 |
|
| Net cash used in operating activities |
|
| (14,920 | ) |
|
| (3,433 | ) |
|
|
|
|
|
|
|
|
|
|
| Cash flows from investing activities |
|
|
|
|
|
|
|
|
| Net cash used in investing activities |
|
| — |
|
|
| — |
|
|
|
|
|
|
|
|
|
|
|
| Cash flows from financing activities |
|
|
|
|
|
|
|
|
| Proceeds from advance from stockholder - related parties |
|
| — |
|
|
| 2,500 |
|
| Proceeds from convertible notes payable — related parties |
|
| 18,000 |
|
|
| — |
|
| Proceeds from sale of common stock |
|
| — |
|
|
| 8,000 |
|
| Net cash provided by financing activities |
|
| 18,000 |
|
|
| 10,500 |
|
|
|
|
|
|
|
|
|
|
|
| Effect of exchange rate changes on cash |
|
| 50 |
|
|
| — |
|
| Net increase in cash |
|
| 3,130 |
|
|
| 7,067 |
|
| Cash, beginning of period |
|
| 10,838 |
|
|
| 1,252 |
|
| Cash, end of period |
| $ | 13,968 |
|
| $ | 8,319 |
|
|
|
|
|
|
|
|
|
|
|
| Supplemental cash flow information |
|
|
|
|
|
|
|
|
| Cash paid for interest |
| $ | — |
|
| $ | — |
|
| Cash paid for income taxes |
|
| — |
|
|
| — |
|
| Non-cash financing activity: expenses paid by director on behalf of the Company, recorded as loans payable — related party (Note 4) |
|
| 1,027 |
|
|
| — |
|
The accompanying notes are an integral part of these unaudited condensed financial statements.
| F-22 |
| Table of Contents |
NOTES TO THE CONDENSED FINANCIAL STATEMENTS (UNAUDITED)
May 31, 2026
(expressed in US dollars)
Note 1 — Nature of Operations and Going Concern
Elements Ventures Group Inc. (the “Company”) was incorporated in the State of Wyoming on January 31, 2022. The Company is developing FITLY, an artificial-intelligence-enabled fitness and nutrition application intended to be delivered as a hosted, subscription-based service. The Company has not generated revenue and its operations to date have consisted of organizational activities, product feasibility analysis and development, and preparation of a registration statement on Form S-1, which was filed with the Securities and Exchange Commission (the “SEC”) on July 17, 2026.
Going concern
The accompanying condensed financial statements have been prepared assuming the Company will continue as a going concern. In accordance with ASC 205-40, management has evaluated whether conditions and events, considered in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued.
The following conditions and events raise substantial doubt: (i) the Company has generated no revenue since inception and has incurred recurring losses, including a net loss of $14,908 for the nine months ended May 31, 2026, resulting in an accumulated deficit of $156,402; (ii) at May 31, 2026 the Company had cash of $13,968, total current liabilities of $110,803 and a working capital deficit of $96,835; (iii) convertible notes payable to related parties in the aggregate principal amount of $23,000 had matured between September 28, 2024 and May 13, 2026 and remain unpaid, each an event of default entitling the holder to accelerate, a further $15,000 convertible note matures on November 25, 2026, and the Company’s $15,000 non-interest bearing stockholder advance and $47,897 of loans from its director are repayable on demand; (iv) the Company used $14,920 of cash in operating activities during the nine months ended May 31, 2026 and has funded its operations entirely through loans from its director and related parties and sales of common stock; and (v) management estimates that a minimum of approximately $80,000 is required to implement its plan of operations for the next twelve months.
Management’s plans are: (i) to raise up to $2,100,000 of gross proceeds in a self-underwritten, best-efforts public offering of up to 6,000,000 shares of common stock at $0.35 per share under the registration statement on Form S-1, which has not been declared effective; the offering has no minimum, no commitments have been received, and completion is outside the Company’s control; (ii) to rely on the verbal, non-binding agreement of the Company’s sole officer and director to loan funds sufficient to maintain minimal operations; and (iii) to seek additional related-party or third-party loans, for which it has no agreements or commitments. Management has concluded that these plans are not probable of being effectively implemented within one year after the date these financial statements are issued and do not alleviate the substantial doubt. Substantial doubt about the Company’s ability to continue as a going concern exists. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
| F-23 |
| Table of Contents |
Note 2 — Summary of Significant Accounting Policies
Basis of presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and with the instructions to Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended May 31, 2026 are not necessarily indicative of the results that may be expected for the year ending August 31, 2026. These condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended August 31, 2025 included elsewhere in the registration statement of which these statements form a part. The balance sheet at August 31, 2025 has been derived from those audited financial statements. The Company’s fiscal year ends on August 31; its functional and reporting currency is the US dollar.
Use of estimates
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingencies. Significant estimates include the useful lives of property and equipment, the valuation allowance on deferred tax assets, the assessment of embedded features in convertible notes and the going-concern evaluation. Actual results could differ from those estimates.
Software development costs
The Company accounts for the costs of developing the FITLY application, which is intended to be provided as a hosted, subscription-based service, under ASC 350-40, Internal-Use Software. Costs incurred during the preliminary project stage, including project feasibility analysis, are expensed as incurred; qualifying application-development-stage costs would be capitalized once the preliminary project stage is complete, management has committed to funding the project and completion is probable; post-implementation costs are expensed. During the years ended August 31, 2025 and 2024, the Company expensed $5,950 and $14,000, respectively, of third-party project feasibility analysis costs within consulting charges. During the nine months ended May 31, 2026, the Company incurred $827 of subscription charges for AI development tools and $200 of website development costs, which were paid by the Company’s director on its behalf (Note 4) and expensed within general and administrative expenses; the tool subscriptions are period costs and the website amount is not material to capitalize. The remaining development of the application has been performed by the Company’s sole officer and director. No development costs have been capitalized and no intangible asset is recorded. Research and development costs, if any, are expensed as incurred in accordance with ASC 730.
| F-24 |
| Table of Contents |
Convertible notes payable
The Company accounts for convertible notes payable under ASC 470-20, as amended by ASU 2020-06, which the Company adopted as of September 1, 2021. A convertible note is accounted for as a single liability at amortized cost unless the conversion feature must be bifurcated as a derivative under ASC 815 or the note was issued at a substantial premium. Each of the Company’s convertible notes is convertible, at the holder’s option prior to maturity, into a fixed number of shares of common stock at a fixed conversion price of $0.015 per share, is settled only in shares, contains no anti-dilution, price-reset, variable-conversion or cash-settlement provisions, and provides that accrued interest is payable in cash. The Company has concluded that the conversion features are indexed to its own stock and would be classified in stockholders’ equity, and therefore qualify for the scope exception in ASC 815-10-15-74(a); in addition, they do not meet the net-settlement characteristic of a derivative because the Company’s shares are not readily convertible to cash. Accordingly, no embedded derivative has been bifurcated, no beneficial conversion feature is recognized, and each note is carried at the principal advanced plus accrued interest. None of the notes was issued at a premium.
Related parties; expenses paid by related parties
The Company follows ASC 850, Related Party Disclosures (see Note 4). Expenses paid by a related party on the Company’s behalf are recognized as expenses of the Company with a corresponding increase in the amount due to the related party, and are presented as non-cash financing activities in the statement of cash flows.
Foreign currency
The Company maintains a Canadian-dollar bank account and incurs certain expenses in Canadian dollars. Monetary items are remeasured at period-end rates and expenses at average rates (ASC 830). Translation differences arising from the Canadian-dollar account are reported in other comprehensive income (loss); transaction gains and losses ($57 and $56 for the three and nine months ended May 31, 2026; none in 2025) are presented with the translation adjustment in other comprehensive income (loss) because they are not material.
Loss per share
Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding. Diluted loss per share gives effect to potentially dilutive shares using the if-converted method unless anti-dilutive. Because the Company incurred net losses in all periods, diluted loss per share equals basic loss per share. Potentially dilutive shares excluded from the computation consisted of 2,533,333 shares issuable upon conversion of convertible notes at May 31, 2026 (733,333 at May 31, 2025), of which 1,000,000 relate to a note whose conversion right is currently exercisable (Note 4). Weighted average shares for the three and nine months ended May 31, 2025 include the 26,667 shares issued on May 23, 2025 from that date.
Other policies
The Company’s other significant accounting policies — cash, property and equipment (straight-line depreciation over five years), fair value of financial instruments, income taxes (asset-and-liability method with a full valuation allowance), comprehensive loss and revenue recognition under ASC 606 (no revenue to date) — are described in Note 2 to the audited financial statements for the year ended August 31, 2025 and have been applied consistently. The Company has reviewed recently issued accounting pronouncements and does not believe any will have a material effect on its financial statements.
| F-25 |
| Table of Contents |
Note 3 — Property and Equipment
|
|
| May 31, 2026 |
|
| August 31, 2025 |
| ||
| Computers |
| $ | 2,589 |
|
| $ | 2,589 |
|
| Printers |
|
| 921 |
|
|
| 921 |
|
| Property and equipment, gross |
|
| 3,510 |
|
|
| 3,510 |
|
| Less: accumulated depreciation |
|
| (2,223 | ) |
|
| (1,697 | ) |
| Property and equipment, net |
| $ | 1,287 |
|
| $ | 1,813 |
|
Depreciation expense was $177 and $157 for the three months ended May 31, 2026 and 2025, respectively, and $525 and $466 for the nine months ended May 31, 2026 and 2025, respectively. There were no additions or disposals during the nine months ended May 31, 2026.
Note 4 — Related Party Transactions and Notes Payable
Loans from director
Dmitry Kinslikh, the Company’s sole officer, director and principal stockholder, has advanced funds to the Company for working capital since inception. At August 31, 2025 the Company owed Mr. Kinslikh $46,870. During the nine months ended May 31, 2026, Mr. Kinslikh paid $1,027 of expenses on the Company’s behalf — $827 of subscription charges for AI development tools and $200 of website development costs — which were recognized as general and administrative expenses with a corresponding increase in the amount due to him; no cash was advanced or repaid during the period. At May 31, 2026 the Company owed Mr. Kinslikh $47,897. The loans are unsecured, non-interest bearing, due on demand and not evidenced by written instruments. Mr. Kinslikh has verbally agreed to loan the Company funds sufficient to maintain minimal operations; this agreement is not legally binding. During the nine months ended May 31, 2025, the Company paid Mr. Kinslikh consulting fees of $3,000 for management and administrative services; no consulting fees were paid during the nine months ended May 31, 2026. Mr. Kinslikh receives no salary and has personally performed the development of the FITLY application. The Company evaluated the fair value of these services and concluded that the consulting fees paid, together with the $400 of share-based compensation recognized in fiscal 2022 (Note 5), reasonably reflect the cost of the services provided, and that the incremental fair value of any uncompensated services is not material to the financial statements.
Advance from stockholder
On July 24, 2023, the Company received an advance of $12,500 from Jasbir Gill, a stockholder of the Company. The advance is unsecured, non-interest bearing, has no stated maturity, is repayable on demand, carries no conversion rights and is not evidenced by a written instrument. The balance was $12,500 at May 31, 2026 and August 31, 2025. Mr. Gill holds 500,000 shares of the Company’s common stock and is the father of Jaswinder Gill and Tejpal Gill, who are also stockholders of the Company.
On February 10, 2025, the Company received an advance of $2,500 from Flex Bricks Ltd, a company controlled by Gurjeet Kooner stockholder of the Company. The advance is unsecured, non-interest bearing, has no stated maturity, is due on demand, carries no conversion rights and is not evidenced by a promissory note or other written instrument. The balance outstanding was $2,500 at August 31, 2025.
| F-26 |
| Table of Contents |
Convertible notes payable — related parties
| Holder / date of note |
| Principal |
|
| Rate |
|
| Maturity |
| Fixed conversion shares |
|
| Conversion price |
|
| Status at May 31, 2026 | |||||
| Capitale Matador Ltee — Nov. 24, 2023 |
| $ | 5,000 |
|
|
| 5 | % |
| Nov. 23, 2024 |
|
| 333,333 |
|
| $ | 0.015 |
|
| Matured; unpaid | |
| Capitale Matador Ltee — Apr. 1, 2024 |
|
| 6,000 |
|
|
| 5 | % |
| Sep. 28, 2024 |
|
| 400,000 |
|
| $ | 0.015 |
|
| Matured; unpaid | |
| El Toro Capital Build Ltd — Aug. 27, 2025 |
|
| 9,000 |
|
|
| 5 | % |
| Feb. 23, 2026 |
|
| 600,000 |
|
| $ | 0.015 |
|
| Matured; unpaid | |
| El Toro Capital Build Ltd — Nov. 14, 2025 |
|
| 3,000 |
|
|
| 5 | % |
| May 13, 2026 |
|
| 200,000 |
|
| $ | 0.015 |
|
| Matured; unpaid | |
| El Toro Capital Build Ltd — May 29, 2026 |
|
| 15,000 |
|
|
| 5 | % |
| Nov. 25, 2026 |
|
| 1,000,000 |
|
| $ | 0.015 |
|
| Current | |
| Total |
| $ | 38,000 |
|
|
|
|
|
|
|
|
| 2,533,333 |
|
|
|
|
|
|
| |
During the nine months ended May 31, 2026, the Company issued the November 14, 2025 note for $3,000 and the May 29, 2026 note for $15,000 (funded $7,500 on May 27, 2026 and $7,500 on May 29, 2026). Each note bears interest at 5% per annum, computed on a 365-day basis on the principal advanced, with principal and accrued interest due at maturity; is convertible at the holder’s option at any time prior to maturity into the fixed number of common shares shown above ($0.015 per share), with accrued interest payable in cash on conversion; may not be prepaid without the holder’s consent; is unsecured; and permits the holder to declare all amounts immediately due upon an event of default, including failure to pay when due. The notes are governed by the laws of the Province of Ontario. The executed instrument for the August 27, 2025 note erroneously states a principal amount of $12,000 convertible into 800,000 shares; $9,000 was advanced under that note and the further $3,000 was advanced on November 14, 2025 under its own note, and the Company records the notes at the amounts advanced (the instrument was corrected by an amendment dated as of August 31, 2026 — see Note 6).
Notes with an aggregate principal of $23,000 have matured and had not been repaid at May 31, 2026 or at the date these financial statements were issued; the holders have not demanded payment or exercised their acceleration remedies, and interest continues to accrue at the contractual rate. On August 31, 2026, subsequent to the period end, the notes were amended to extend their maturity dates to August 31, 2027, to waive the prior payment defaults and to confirm that the conversion rights remain in full force and effect (see Note 6). All convertible notes are classified as current liabilities.
Interest expense on the notes was $296 and $139 for the three months, and $836 and $410 for the nine months, ended May 31, 2026 and 2025, respectively. Accrued interest payable was $1,706 at May 31, 2026 ($871 at August 31, 2025), consisting of $628 on the $5,000 note, $649 on the $6,000 note, $342 on the $9,000 note, $81 on the $3,000 note and $6 on the $15,000 note.
Capitale Matador Ltee is controlled by Elena Znamenskaya, who has voting and dispositive power over its shares. Ms. Znamenskaya holds 300,000 shares of the Company’s common stock directly and beneficially owns the 20,000 shares held by Capitale Matador Ltee, which it purchased from the Company in fiscal 2024. Roman Znamenski, her son, holds 700,000 shares of the Company’s common stock (approximately 5.9%). El Toro Capital Build Ltd is controlled by Marlis Guerra, who has voting and dispositive power over its shares and holds no shares of the Company in her own name; it purchased 26,667 shares from the Company for $8,000 on May 23, 2025.
| F-27 |
| Table of Contents |
Summary of amounts due to related parties
|
|
| May 31, 2026 |
|
| August 31, 2025 |
| ||
| Loans from director, non-interest bearing, due on demand |
| $ | 47,897 |
|
| $ | 46,870 |
|
| Advance from stockholder, non-interest bearing, repayable on demand |
|
| 15,000 |
|
|
| 15,000 |
|
| Convertible notes payable, 5% |
|
| 38,000 |
|
|
| 20,000 |
|
| Accrued interest payable on convertible notes |
|
| 1,706 |
|
|
| 871 |
|
| Total due to related parties (all current) |
| $ | 102,603 |
|
| $ | 82,741 |
|
Note 5 — Stockholders’ Deficit
The Company is authorized to issue 500,000,000 shares of common stock and 20,000,000 shares of preferred stock, each with a par value of $0.0001, of which 5,000,000 preferred shares are designated Series A Preferred Stock (10,000 votes per share; convertible into 10,000 common shares per share; none issued). No shares of common or preferred stock were issued during the nine months ended May 31, 2026. During the nine months ended May 31, 2025, the Company issued 26,667 shares of common stock to El Toro Capital Build Ltd, a related party, for $8,000. There were 11,817,167 shares of common stock outstanding at May 31, 2026 and August 31, 2025, including 7,000,000 shares issued to the Company’s sole officer and director in February 2022 for aggregate consideration of $700, consisting of $300 in cash and services valued at $400 recognized as share-based compensation in fiscal 2022. At May 31, 2026, 2,533,333 shares of common stock were reserved for issuance upon conversion of the convertible notes described in Note 4. Conversion of all designated Series A Preferred Stock, if issued, would require more common shares than are authorized; any issuance would require an increase in authorized shares or a limitation on conversion.
Note 6 — Subsequent Events
The Company evaluated all events or transactions that occurred after May 31, 2026, through June 12, 2026, no other subsequent events were identified requiring recording or disclosure in the financial statements for the nine months ended May 31, 2026.
| F-28 |
| Table of Contents |
PART II - INFORMATION NOT REQUIRED IN
PART II - INFORMATION NOT REQUIRED IN PROSPECTUS
OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
The following table sets forth the estimated expenses in connection with the issuance and distribution of the securities being registered hereby. All such expenses will be borne by the Company.
| SEC Registration Fee |
| $ | 522.85 |
|
| Auditors Fees and Expenses |
| $ | 10,000 |
|
| Legal Fees and Expenses |
| $ | 10,000 |
|
| Transfer Agent Fees |
| $ | 2,000 |
|
| EDGAR Agent Fees |
| $ | 2,000 |
|
| Miscellaneous |
| $ | 477.15 |
|
| Total |
| $ | 25,000 |
|
INDEMNIFICATION OF DIRECTORS AND OFFICERS
The Wyoming Business Corporation Act, including W.S. §§ 17-16-851 through 17-16-858, provides for the indemnification of directors and officers under certain circumstances. In general, W.S. § 17-16-851 permits us to indemnify a director who is made a party to a proceeding because of his or her status as a director if the director acted in good faith, reasonably believed that his or her conduct was in or at least not opposed to our best interests and, in the case of a criminal proceeding, had no reasonable cause to believe that the conduct was unlawful. Wyoming law also requires indemnification of a director who is wholly successful, on the merits or otherwise, in the defense of a proceeding because the individual was a director, for reasonable expenses incurred in connection with the proceeding.
Wyoming law also permits the advancement of expenses to directors subject to certain conditions, including, where applicable, an undertaking to repay the amounts advanced if it is ultimately determined that the director is not entitled to indemnification. Officers may be indemnified and have expenses advanced to them to the same extent as directors and, in certain circumstances, to a broader extent permitted by our governing documents and Wyoming law.
Article XI of our Bylaws provides that we will indemnify our directors and officers to the fullest extent permitted by the Wyoming Business Corporation Act. Our Bylaws also provide for the advancement of expenses incurred by directors and officers in defending covered proceedings, subject to the requirements of Wyoming law, including an undertaking to repay such amounts if it is ultimately determined that the person is not entitled to indemnification. Article XI further provides procedures for seeking indemnification, provides that the rights to indemnification and advancement are not exclusive of other rights available under applicable law or agreement and permits us to maintain insurance for our directors, officers, employees and agents.
Wyoming law also permits us to purchase and maintain insurance on behalf of our directors and officers against liabilities asserted against or incurred by them in such capacities, whether or not we would otherwise have the power to indemnify them against such liabilities.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing provisions or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
RECENT SALES OF UNREGISTERED SECURITIES
Within the past three years we have issued and sold the following securities without registration:
| II-1 |
| Table of Contents |
During the year ended August 31, 2022, the Company issued 7,000,000 shares to Dmitry Kinslikh, its sole officer and director, subscribed on January 31, 2022 pursuant to the Company’s organizational consent and issued on February 17, 2022, for aggregate consideration of $700, consisting of $300 in cash (received February 24, 2022) and services rendered to the Company by Mr. Kinslikh valued at $400, which was recognized as share-based compensation in fiscal 2022; and 4,740,500 shares to 34 other investors between February 7 and June 30, 2022 at prices ranging from $0.0001 to $0.10 per share for aggregate cash consideration of $39,110, for total fiscal 2022 consideration of $39,810 ($39,410 in cash and $400 in services). The fair value of the founder shares was measured at $0.0001 per share, the price at which unrelated investors purchased shares for cash in contemporaneous transactions. During the year ended August 31, 2023, the Company issued 30,000 shares to three investors at $0.25 per share for cash proceeds of $7,500. During the year ended August 31, 2024, the Company issued 20,000 shares to Capitale Matador Ltee, at $0.30 per share for cash proceeds of $6,000. During the year ended August 31, 2025, the Company issued 26,667 shares to El Toro Capital Build Ltd., at $0.30 per share for cash proceeds of $8,000.
On November 14, 2025, the Company issued a convertible promissory note to El Toro Capital Build Ltd in the principal amount of $3,000, bearing interest at 5% per annum, maturing May 13, 2026 and convertible prior to maturity into 200,000 shares of common stock at $0.015 per share, representing the further advance contemplated when the August 27, 2025 note was signed.
The convertible note dated August 27, 2025 matured on February 23, 2026 and the note dated November 14, 2025 matured on May 13, 2026; neither had been repaid, the holder did not demand payment, and interest continued to accrue. On August 31, 2026, the Company entered into omnibus amendments with the holders of its five convertible promissory notes, extending the maturity date of each note to August 31, 2027, waiving the events of default arising from non-payment at the original maturity dates, and confirming that the conversion rights remain in full force and effect on their existing terms; no fee was paid and the interest rate was unchanged. The amendment to the August 27, 2025 note also corrected its principal amount to $9,000 and its conversion shares to 600,000.
On May 29, 2026, the Company issued a convertible promissory note to El Toro Capital Build Ltd in the principal amount of $15,000, funded $7,500 on May 27, 2026 and $7,500 on May 29, 2026, bearing interest at 5% per annum, maturing November 25, 2026 and convertible prior to maturity into 1,000,000 shares of common stock at $0.015 per share.
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
The following exhibits are filed as part of this registration statement:
*Previously Filed
| II-2 |
| Table of Contents |
UNDERTAKINGS
The undersigned Registrant hereby undertakes:
|
| (a) | (1) | To file, during any period in which offers or sales of securities are being made, a post-effective amendment to this registration statement to: |
|
|
|
| (i) | Include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |
|
|
|
|
|
|
|
|
|
| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) (§230.424(b) of this chapter) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement. |
|
|
|
|
|
|
|
|
|
| (iii) | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; |
|
| (2) | That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
|
|
|
|
|
| (3) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
|
|
|
|
|
| (4) | That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: |
|
| (i) | If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. |
|
| (5) | That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
|
| (i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
|
|
|
|
|
| (ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
|
|
|
|
|
| (iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or our securities provided by or on behalf of the undersigned registrant; and |
|
|
|
|
|
| (iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
Insofar as indemnification for liabilities arising under the Securities Act of 1933 (the “Act”) may be permitted to our directors, officers and controlling persons pursuant to the provisions above, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities, other than the payment by us of expenses incurred or paid by one of our directors, officers, or controlling persons in the successful defense of any action, suit or proceeding, is asserted by one of our directors, officers, or controlling persons in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification is against public policy as expressed in the Securities Act, and we will be governed by the final adjudication of such issue.
| II-3 |
| Table of Contents |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Vaughan, Provide of Ontario on the 7th day of October, 2026.
| Elements Ventures Group Inc. | |||
|
| |||
|
| By: | /s/ Dmitry Kinslikh |
|
|
| Name: | Dmitry Kinslikh |
|
|
| Title: | President | |
In accordance with the requirements of the Securities Act of 1933, the following persons in the capacities and on the dates stated signed this registration statement
| Signature |
| Title |
| Date |
|
|
|
|
|
|
| /s/ Dmitry Kinslikh |
| President, Treasurer and Director (Principal Executive, Financial and Accounting Officer) |
| October 7, 2026 |
| Dmitry Kinslikh |
|
|
|
|
| II-4 |